




MANIPULATORS OF MENDING 
Campbell Bruce Gilbert 
 
  
University of Otago 
Dunedin 
 
31st May 2021 
A thesis submitted for the partial fulfilment of the requirements for the degree of 






Recent work in our lab has uncovered an interesting connection between regeneration 
and the skin microbiome [1] [2]. Culturing tadpoles of the species Xenopus laevis in the 
antibiotic gentamicin has been shown to reduce the rate of successful tail regeneration 
following amputation. The addition of heat killed Escherichia coli to these gentamicin 
treated tadpoles rescued the successful regeneration phenotype. Furthermore, 16s 
rRNA sequencing showed that the skin microbiome of tadpoles in which regeneration 
was successful was distinct from those where regeneration failed. Successful 
regenerates correlated with high gram-negative skin microbiota levels [3], supporting 
the suggestion that gram-negative bacteria may play a role in regenerative success. This 
previous work also showed that activity in the NF-κB pathway increased upon 
amputation of the tadpole tail, indicating an immune response was triggered by the 
amputation process.  
These discoveries led to the generation of a hypothesis: the exposure of host immune 
cells to skin microbes during tail amputation induces an immune response that is 
required to trigger regeneration in Xenopus laevis tadpoles. The primary immune 
receptor responsible for the recognition of gram-negative bacteria is Toll-like receptor 
4 (Tlr4), which has evolved to recognise a major structural component in the outer 
membrane of gram-negative bacteria called Lipopolysaccharide (LPS) [4]. It is this 
interaction between host Tlr4 and bacterial LPS that may provide the link between skin 
microbiome and regeneration. This connection between skin microbiome and 
regenerative success of a complex appendage in a vertebrate system has not been 
published anywhere in the current literature and is incredibly exciting. Furthering our 
understanding in the rapidly evolving field of regeneration is crucial if we wish to one 
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1.1 The microbiome 
Not every cell on, or within your body is a human cell. We share our bodies with trillions 
of microscopic organisms including bacteria, archaea, fungi, and viruses; collectively 
known as the microbiome. The human microbiome has been a topic of interest for 
researchers for many years now, however the traditional method of studying the 
microbiome involved manual culturing of relatively few microbial species, and progress 
was slow [5]. In 2012 the Human Microbiome Project Consortium (HMP) published 
their framework for human microbiome research incorporating the use of next 
generation sequencing [6], which opened the door for many subsequent investigations 
and discoveries. This, and the majority of papers to follow it were metagenomic studies 
that applied 16s rRNA sequencing to selectively amplify bacterial DNA [7]. It was 
quickly discovered by the HMP that the composition of the microbiome varies greatly 
between healthy individuals, as well as between the different niches within a single 
individual [8]. This indicates that high levels of microbiome variation are normal and 
may impact on host-microbiome interactions. This niche specialization has been further 
studied with particular focus on the skin microbiome of humans [9], where the same 
high levels of composition variation have been observed as in the entire microbiome. 
Studies in mice uncovered similar variation in their skin microbiome [10], indicating 
that this is not a human specific phenomenon. The microbiome possessed by any given 
individual is personalized, and there is evidence that changes to its composition over 
time are limited as it remains largely stable [11].  
The human microbiome influences virtually all aspects of human health [12]. Among the 
many studies on the topic; lean and obese human twin pairs have been utilized to 
shown that phylum level microbial composition correlates with obesity [13], and 
studies have shown that the gut microbiome may go as far as to influence immunity [14] 
and play a role in mood, anxiety, and the central nervous system [15]. Not only do the 




as competition and niche occupation play a vital role in protection against pathogens 
[16]. For example, antibiotic treatments can lead to proliferation of the pathogen 
Clostridium difficile due to decreased competition for nutrients, potentially causing 
diarrhoea [17]. Just as the microbiome can influence the host, the opposite is also true 
as host factors such as age, sex, diet [18], hygiene, medication and lifestyle can impact 
the composition of the human microbiome [19]. As eluded to earlier, humans are not 
the only species to host a microbiome; in fact, all macroscopic eukaryotes carry their 
own army of microscopic organisms.  
1.2 Xenopus laevis as a model organism 
One such species, and the model organism used for my research is the African Clawed 
Frog Xenopus laevis. This fully aquatic frog has become a favourite among researchers in 
the fields of developmental biology and genetics due to the ease and flexibility of 
experimentation with this model [20]. One particular strength this model organism 
boasts is the ability to study complicated developmental processes such as 
regeneration, which is of particular interest to our lab [21]. 
Numerous features of X. laevis make it an excellent model for research [22], many of 
which are outlined by the online tool Xenbase [23]. Xenbase is a database with extensive 
information on Xenopus’ lifecycle and development, genome information, background 
literature, and experimental protocols. Female X. laevis frogs lay a large batch of eggs 
that are fertilized and develop externally, allowing for experiments to be performed on 
them early after, or even before fertilization. Many studies utilise X. laevis as their model 
due to the characteristics of their embryos; such as their large size (1-1.3 mm), 
resistance to extensive manipulations such as dissection [24], and the ease of 
microinjection of various materials (e.g. Proteins, nucleic acids, or whole nuclei [25]). 
Researchers have the ability to easily induce females into laying eggs via human 
chorionic gonadotropin injection [26], making X. laevis one of very few frog species 
where ovulation can be so carefully controlled. Embryos develop quickly, forming a 
tadpole containing fully functional organs after only two days, allowing examination of 
experimental outcomes to be rapid. The complete developmental cycle of X. laevis from 
embryo to the end of metamorphosis has been known since 1994 [27] and the cell fate 
of each early embryonic cell is well established. This allows for targeted gene knock-out 




Xenopus laevis is an allotetraploid meaning it has four sets of chromosomes (haploid = 
18 chromosomes), compared to the two sets of chromosomes in a diploid organism 
such as humans or the closely related Xenopus tropicalis [28]. This allotetraploid 
phenotype is suggested to have arisen evolutionarily after the combination of two 
separate diploid progenitor species around 17-18 million years ago [29]. These two 
sub-genomes have since evolved asymmetrically, with one sub-genome experiencing 
more loss of genetic material and rearrangement, to the point where it now produces 
chromosomes that are shorter than the other sub-genome. They are thus designated as 
either the ‘S’ sub-genome (short) or ‘L’ sub-genome (long). Although purifying selection 
will often result in the deletion of extra copies of a gene following gene duplication [30], 
more than 56% of all duplicated genes have been maintained in the X. laevis genome 
[29]. This can complicate genetic experiments due to the potential for copies of each 
gene to exist in all four sets of chromosomes, a factor which must be considered when 
designing genetic knockouts or knockdowns. X. laevis has a genome size of 3.1 x 109 bp, 
making it slightly larger than the human genome. Strikingly, it has been shown that the 
genus Xenopus displays remarkable similarity in genome structure to humans [31], 
supporting the phylogenetic classification of Xenopus as one of the closest relatives to 
humans of all the animal models commonly used for biomedical research [32]. This 
means the findings of Xenopus studies have great significance toward the research of 
human conditions and diseases.  
1.3 Regeneration: more than healing 
As of 2021, it has been 253 years since the first scientific publication on regeneration 
back in 1769, which focussed on the regrowth of salamander legs [33]. Since that time, 
our knowledge on the topic has expanded greatly, although much of the specific detail 
on how this phenomenon occurs remains elusive to this day. Regeneration is a 
remarkably complex process, but not an uncommon one as many species possess some 
form of wound healing or regenerative ability [34], even humans. Although in adult 
humans, wound healing usually results in the formation of a non-functioning mass of 
fibrotic tissue, called scar tissue, foetal tissues damaged early after gestation can 
completely reform without fibrosis [35]. The potential to unlock these latent 
regenerative abilities possessed by humans is what drives research on species with 




Regeneration comes in many forms and can be broadly categorised based on the tissue 
being regenerated and the associated complexity of the regeneration; as reviewed by 
Tsonis, P.A. (2000) [36]. The simplest form of regeneration is axonal outgrowth 
observed in severed nerves. More complex than this but still relatively simple is the 
proliferation of cells in certain damaged organs such as the liver or adrenal gland [37]. 
Regeneration of these organs can be achieved via proliferation of the adult cells that 
compose that organ. To regenerate other organs however, proliferation and 
differentiation of stem cells must be accomplished, delineating a much more complex 
series of cell signalling events [38]. The most complex forms of regeneration involve 
dedifferentiation of mature cells near the site of damage to a state of near pluripotency, 
where they become capable of giving rise to a range of cell types in a manner similar to 
stem cells, before redifferentiation into the required cell type [39]. This is an ability that 
is exceedingly rare in vertebrates and has mainly been observed in amphibia, which 
have become the animal models of choice when studying regeneration due to their 
unparalleled regenerative abilities [40, 41].  
1.3.1 Regeneration in Xenopus laevis 
To date, most regeneration studies are carried out on Urodeles, an order of amphibians 
that retain a post-anal tail throughout their lifespan [42, 43]. Xenopus, however, is of the 
order Anura and is often utilised in regeneration studies due to the simplicity of 
experimentation and the ability to carry out these experiments early in tadpole 
development [44]. X. laevis tadpole tail regeneration has been shown by our lab [45] 
and many others [46, 47] to be a powerful tool for studying spinal cord regeneration. X. 
laevis tails contain a spinal cord, notochord and segmented muscles which can all fully 
regenerate following amputation of the tail, often carried out experimentally by use of a 
scalpel blade [48]. The regenerated tail has only slight differences to wild type, such as 
an immature spinal cord and incomplete segregation of muscle masses [49]. 
Unsurprisingly, several literature reviews on the topic have previously been published 
[48, 50-52] and a model of this tail regeneration has been established. In this model 
there are three stages to the regeneration event.  
The early phase comprises the first six hours after tail amputation during which scar-
less wound healing can be observed as epithelial cells migrate to enclose the wound 




regeneration, such as an acute inflammatory response, electric polarization of the 
injured tail by the vacuolar ATPase H+ pump [54] and the apoptosis of a number of cells 
at the injury site [55]. The intermediate phase takes place roughly 24-36 hours after tail 
amputation and is characterised by the formation of a dynamic patch of regenerative 
tissue called the ‘regenerative bud’ [56]. This regenerative bud contains the progenitor 
cells that will reform the tail and is thus analogous to the blastema that forms during 
limb regeneration of Urodeles [57]. Regenerative bud cells are classed as lineage-
restricted stem cells and do not undergo metaplasia (an abnormal change in the nature 
of the tissue) [58]. Instead, each tissue of the tadpole tail regenerates from its 
corresponding tissue-specific stem cell in the tail stump [59, 60]. The final stage of tail 
regeneration is the late phase and takes place over the next 5-9 days following the 
intermediate phase. This is when the regenerate tail is formed as the spinal cord, 
notochord, and muscle tissues all proliferate from their respective stem cells.  
Understanding of X. laevis tail regeneration has increased greatly over the last few 
years. One discovery made by our lab was that the normally very robust ability to 
regenerate a severed tail is temporarily lost for a ‘refractory period’ between 
developmental stage 45-47 [61]. This refractory period can be very useful for studying 
regeneration-altering interventions, as methods of rescuing regeneration during this 
phase can be trialled, as well as methods for knocking out regeneration outside of this 
phase. The refractory period is most obvious in tadpoles cultured in a sterile 
environment and comes to an end when the tadpole’s transition to stage 48 and require 
feeding for the first time, thus ending the sterile nature of their upbringing. Studying 
this refractory period in our lab facilitated the discovery of important cell signalling 
pathways during tail regeneration, including Bone Morphogenic Protein (BMP) and 
Notch signalling [61]. Importantly for this project, the NF-κB cell signalling pathway 
was discovered to be activated briefly in tadpoles which had successfully regenerated 
their tails, while deactivating this pathway functionally reduced regenerative success 
[1]. NF-κB is a transcription factor and a pivotal mediator of inflammation [62], 
implicating the immune system in regeneration and identifying the skin microbiome as 
a possible trigger for this immune response. Delving further identified a correlation 
between high levels of gram-negative bacteria in the X. laevis skin microbiome and 
regenerative success, and that culturing X. laevis tadpoles in a broad-spectrum antibiotic 




killed gram-negative Escherichia coli to these gentamicin treated tadpoles rescued their 
regeneration [2]. These findings suggest an intimate link between the skin microbiome 
hosted by a X. laevis tadpole and its ability to regenerate an amputated tail, which this 
research project aims to investigate thoroughly.  
1.4 Innate immunity and the link to regeneration 
The potential link between regeneration and the microbiome is the immune system. We 
typically recognise two broad categories of immune system; the innate immune system 
that nearly all multicellular organisms have, and the adaptive immune system that is 
unique to vertebrates. Whilst the adaptive immune system is a broader and more finely 
tuned system for recognising and eliminating foreign material [63], the innate immune 
system is more relevant to this research, and particularly to regeneration. The innate 
immune response, specifically regulation of inflammation, has been strongly linked to 
regenerative success in a number of amphibians such as salamanders, newts, and 
Xenopus [64-66], as well as in mammals [67, 68]. For instance, studies on X. laevis have 
highlighted an important role for myeloid innate immune cells in tissue remodelling and 
apoptotic control to promote a regeneration-competent cellular environment [69], 
although understanding of the underlying cellular events is still in its infancy. The 
innate immune system is characterised by various hematopoietic cells, such as 
macrophages, dendritic cells, mast cells, neutrophils, eosinophils, natural killer cells (NK 
cells), and natural killer T cells [70], each with distinct functions. In addition to this 
cellular component, there are non-cellular circulating elements that also fall under the 
banner of the innate immune system, such as complement proteins, LPS binding protein 
(LBP), and anti-microbial peptides [70].  
The innate immune system has various modes of activation, such as sensing the damage 
caused by an infection [71], recognition of ‘self’ and subsequent inhibition of activation 
[72], or the main method of activation; direct sensing of foreign substances through 
receptor stimulation. These receptors are germline encoded and recognise a limited 
number of highly conserved microbial structures, which is in direct contrast to the 
massive, randomly generated repertoire of antigen receptors boasted by the adaptive 
immune system [73]. This means that the innate immune system is relatively restricted 
in the number of potential microbial targets it can recognise, and the microbe target has 




works around this by targeting microbial structures that are essential to the viability or 
virulence of the microbe, and are thus less prone to mutation [70].  
There are multiple different pattern recognising receptors of the innate immune system, 
including but not limited to: NOD-like receptors, collectin family receptors, and 
macrophage mannose receptors [75], all of which recognise their own microbial feature. 
This research project focused on the most relevant receptor family, the Toll-like 
receptors (TLRs), specifically Toll-like receptor 4. Tlr4 was first discovered to recognise 
microbial structures in 1994 after experiments on Drosophila immunity [76]. Since 
these early experiments we have learned that Tlr4 is a membrane spanning receptor 
protein that recognises Lipopolysaccharide, a prominent feature of gram-negative 
bacteria [4, 77]. ‘Lipopolysaccharide’, or LPS, comprises most of the structural glycolipid 
in the outer membrane of gram-negative bacteria and has been shown to stimulate a 
non-specific immunity response which protects against microbes [78].  
1.4.1 Toll-like receptor 4 – The role of the host in regeneration  
The pathway toward Tlr4 activation has been studied extensively in mammals and is 
well characterised [79]. A prominent feature of Tlr4 signalling is the heavy involvement 
of accessory proteins, such as the protein MD-2 which Tlr4 must be in complex with in 
order to activate [80]. The first steps of Tlr4 activation are carried out by two of these 
accessory proteins, as presented in Figure 1. First, LPS-Binding Protein (LBP) traffics 
LPS to a glycoprotein called CD14. CD14 then separates LPS aggregates into monomers 
and presents them to the Tlr4-MD-2 complex [81]. The LPS monomer then binds to the 
extracellular domain of the Tlr4-MD-2 complex, activating it and causing a conformation 
change which is passed on to the intracellular signalling domain of Tlr4. This domain 
has structural homology to the ‘Interleukin-1 Receptor’ family (IL-1R) and is called the 
Toll/IL-1R homology domain (TIR domain).  
Activation of the TIR domain and the subsequent conformation change triggers 
recruitment of ‘Myeloid Differentiation Factor 88’ (MyD88) [79]. This signal is passed 
on to ‘Interleukin-1 Receptor Associated Kinase’ (IRAK), beginning a signalling cascade 
which ultimately results in the activation of transcription factors such as NF-κB and 
Activator Protein 1. As mentioned previously, NF-κB is a pivotal mediator of the 
inflammatory response and induces the expression of various pro-inflammatory genes 




is the primary purpose of the innate immune system and provides protection against 
pathogen invaders when controlled correctly. 
 
Figure 1: The Tlr4 activation pathway (simplified), adapted from Mukherjee et, al. 2016 [82]. LBP 
delivers the bacterial LPS to CD14, which presents it to MD-2 and ultimately the Tlr4-MD-2 
complex. This signal is then transmitted to the intracellular TIR domain (Toll/interleukin-1 
receptor domain) of Tlr4, which is transmitted to MyD-88, then IRAK. The resulting signalling 
cascade ultimately results in cytokine production mediated by the transcription factor NF-κB. 
Figure created in BioRender. 
 
The innate immune system is common to most multicellular organisms and amphibians 
are no exception. Amphibians bridge the gap between land and water; therefore, their 
skin plays a vital role in how they interact with their environment. It has been shown 
that many amphibian species secrete biologically active components from their skin, 
such as peptides [83, 84]. While some such features are specialised to amphibians, they 
occupy a critical phylogenetic position in the vertebrate lineage regarding the evolution 
of their immune system, as they share many features of cellular immunity with 
mammals [85]. For instance, frogs have a thymus where T-cells differentiate and a 
spleen where B- and T-cells accumulate [86]. They also have leukocytes such as 




found in the blood [86]. For this reason, the study of amphibian innate immunity has 
important implications for research aimed at human health and immunity. This  
research will focus on the gene for Tlr4 (tlr4) found in Xenopus laevis [Xenbase:XB-GENE-
6253925], which is expressed primarily in the myeloid cells of the innate immune system. 
This gene is only found on the S chromosomes and as such there are only two copies 
present in the X. laevis genome. This circumvents much of the difficulty of performing 
genetic experiments on the allotetraploid X. laevis. Tlr4 was selected because it is a 
master regulator of inflammation, and as alluded to previously, is the primary receptor 
responsible for the recognition of gram-negative bacteria. Thus, Tlr4 provides a direct 
link between gram-negative microbial recognition and inflammation, and by extension, 
regeneration. 
1.4.2 Lipopolysaccharide – The role of the microbe in regeneration 
If immunity receptors such as Tlr4 comprise the host component of the host-
microbiome interaction we are interested in here, then Lipopolysaccharide (LPS) 
comprises the microbiome component. As stated earlier, LPS is a major structural 
component in gram-negative bacteria. Gram-negative bacteria are characterised by the 
inclusion of both an inner membrane (IM) which encloses the cytoplasm and its 
components, and an outer membrane (OM) which is exposed to the environment. 
Therefore, LPS not only constitutes an important structural component, but it is also the 
first line of defence for a gram-negative bacterium and is largely responsible for the 
permeability of the OM, offering protection from many hydrophobic antimicrobial 
compounds [87]. Structurally, LPS is a complex and variable molecule which typically 
consists of three distinct structural domains: Lipid A (sometimes referred to as 





Figure 2: The structure of (a.) a typical smooth-type LPS molecule and (b.) a rough-type LPS 
molecule, from Serrato et, al. 2014 [89]. ‘n’ represents the number of repeating oligosaccharide 
units present in the O-antigen of the smooth-LPS. 
 
While overall structure is conserved between species, there can be considerable 
variation in the structure of each of these components [90]. The O-antigen is the most 
distal portion of LPS and is also the most variable in structure. It consists of repeating 
oligosaccharide units, and due to its exposed location as the outermost molecule of the 
bacteria, it is a common target for antimicrobial defences and bacteriophages, which in 
turn drives its variability [91]. The core oligosaccharide is a non-repeating 
oligosaccharide that links the distal O-antigen and the membrane-anchoring Lipid A. 
Variation in this core oligosaccharide is more constrained by the need for structural 




Finally, the most highly conserved domain of an LPS molecule is Lipid A, with structure 
conserved up to species level. The hydrophobic Lipid A molecule comprises much of the 
outer leaflet of the OM, with the inner leaflet comprised mostly of the more common 
membrane molecule, phospholipid. Being the most highly conserved domain, Lipid A 
serves is the primary target of eukaryotic innate immune systems, and is the specific 
ligand recognised by Tlr4. Interestingly, some bacteria have been shown to modify the 
structure of their Lipid A in response to environmental cues such as temperature and 
stress [93, 94], which can alter the virulence of the bacteria under certain conditions. A 
standout example of this is in Yersinia pestis, the bacteria that causes bubonic plague. 
When growing at mammalian body temperature, Yersinia pestis alters the acetylation of 
its Lipid A, greatly reducing its immunogenic properties and helping the bacteria evade 
the host immune response [95].  
A final important consideration regarding LPS is the existence of two broad categories 
of LPS in gram-negative bacteria, smooth and rough. Smooth type LPS refers to the type 
outlined above, with all three structural domains present, while rough type LPS consists 
of the Lipid A and Core Oligosaccharides but lacks the O-antigen domain [96]. These 
rough type LPS are often referred to as lipooligosaccharides (LOS) and although they do 
still trigger the innate immune response through Tlr4 mediated recognition of their 
Lipid A, the mechanism behind this activation may differ slightly to smooth type LPS 
[97]. Often accompanying a change in form is a change in function and LPS is no 
different, with the many varying forms of LPS often interacting with other organisms 
and the environment in subtly different ways depending on structure. An extreme and 
interesting example of this is the LPS found in the bacteria Rhodobacter sphaeroides 
which has been shown to act as an antagonist to Tlr4, the exact opposite interaction 
typical of LPS [98]. The LPS of this species of bacteria competes against other forms of 
LPS for binding to LBP and CD14 without triggering the activation of Tlr4 [99], making 
it a rare case of LPS which does not trigger an immune response.  
1.4.3 Linking the microbiome to regeneration – Moving beyond the literature 
During the course of this two-year project, interest in linking the microbiome to 
regeneration in a range of species has been steadily increasing. Not only does this 
highlight the upward trend in attention that the microbiome has been receiving in 




of the importance of microbes in regeneration. When the immune system, skin, and 
microbes are mentioned together in the literature, it is usually in the context of infection 
and the body’s ability to ward off microbial damage [100]. On the rare occasion where 
some of the focus falls on regeneration, it almost always centres on the gut microbiome 
and regeneration of the gut epithelial cells. It has been shown that a healthy gut 
microbiome can regulate inflammation, protect against pathogens, and stimulate 
regeneration of the epithelial cells that line the gut wall [101] [102]. This is the case in 
humans, many model organisms, and even sea cucumbers [103]. Initially, much of the 
attention was given to the change in microbiome composition that occurs during wound 
healing and gut regeneration. However, recently the topic has expanded to include the 
regenerative effects of the microbiome in different tissues and with a greater focus on 
the impact that these microbes are having on the tissues themselves. Neuron axonal 
regeneration following spinal cord injury has been shown to be stimulated by altering 
the gut microbiome in mice [104], and Lactobacillus reuteri extracts have been shown to 
promote wound healing in mesenchymal stem cells in the human mouth [105]. These 
example papers and many like them are analogous to this project, however their focus 
on relatively simple tissue regeneration denotes where the comparison ends. There are, 
of course, examples focussing on the skin microbiome, such as the effect of bacterial 
lysates on fibroblast regeneration in humans [106], but these too are centred around a 
simpler form of regeneration. As detailed previously, the X. laevis tail is a complex 
appendage and regenerating one is inherently more complicated than simple tissue 
proliferation. Examples of complex regeneration linked to innate immunity in the 
literature are far more infrequent.  
A paper released in April of 2021 by Debuque et, al. [107] is perhaps the most relevant 
to this project, focussing on TLR signalling during limb regeneration in salamanders. 
This study highlighted that the signalling pathway of TLRs within salamanders and mice 
are evolutionarily conserved, although the regulation of these pathways differed under 
non-sterile conditions. When the network of Toll-like receptors of the salamander 
detected cellular damage and pathogenic molecular patterns simultaneously, the 
resulting inflammatory response was found to be more conducive to regeneration than 
that of the mouse under the same conditions. This perfectly highlights the current 
trajectory of regenerative study in the literature, as the evolutionarily honed ability of 




this regeneration is rising to the fore. Where my research steps beyond the published 
literature is in the focus on the skin microbiome as a driver of regeneration. A 
connection between the skin microbiome and regenerative success of a complex 
appendage has, to the best of my knowledge, never been made in the literature. 
A common thread among many papers published on this and similar topics is that this is 
a burgeoning field of research and is worthy of further study. This project aimed to 
continue this line of research, including a targeted gene editing approach to knocking 
out Tlr4 function in X. laevis tadpoles. It stands to reason that a burgeoning field of 
research requires a cutting-edge approach to research, and what better way of 
achieving this tlr4 knockout than the new gold-standard of genetic engineering, 
CRISPR/Cas. 
1.5 CRISPR/Cas – The tool of choice for gene editing experiments 
My research utilised the powerful gene editing technology that is CRISPR/Cas. This 
technology has emerged as the new gold standard for targeted, specific genome 
engineering, and has been shown to be more capable than previous technologies such as 
Zinc finger nucleases and TALENs in many instances [108]. CRISPR-Cas systems are 
possessed by many bacteria and archaea species and provide adaptive immunity 
against viruses [109, 110]. The acronym ‘CRISPR’ stands for ‘Clustered, Regularly 
Interspaced Short Palindromic Repeats’, a term which succinctly describes the CRISPR 
locus. A CRISPR locus consists of an array of short repeating sequences, between each of 
which are short variable sequences called spacers, followed downstream by associated 
Cas proteins [111]. The spacers are acquired from, and thus have sequence homology to 
viral DNA [112]. Upon transcription of the CRISPR array, the repetitive sequences allow 
the associated Cas proteins to process the primary transcript into mature RNA guides 
[113, 114]. CRISPR/Cas immunity is achieved through these sequence-specific small 
guide RNAs which use the spacer sequence to locate and target viral DNA/RNA for 
cleavage by associated Cas nucleases.  
There are three types of CRISPR/Cas system which all differ slightly from one another 
and, in turn, contain sub-classes with further subtle differences. The type-2 system 
functions via a protein called Cas9, which is guided by a small RNA encoded within the 
CRISPR locus (crRNA) and another, trans-encoded small RNA (tracrRNA) [115]. These 




homology to the guide. In addition to sequence homology, this system requires 
recognition of a three base-pair sequence motif downstream of the target called a 
‘Protospacer Adjacent Motif’, or PAM [116], providing additional target verification and 
control against autoimmunity. Upon meeting these requirements, the Cas9 
endonuclease introduces a double-stranded DNA cut at the position three base-pairs 
upstream of the PAM site, inducing degradation of the target DNA [115]. The initial 
sequence of the guide, called the seed sequence, must be complimentary to the target 
[117] and when coupled with the requirement of a PAM site, underpins the unparalleled 
specificity of the CRISPR/Cas system.   
It was quickly recognised that the requirement of RNA guides for CRISPR-Cas9 
mediated DNA cutting allows the system to be programmed toward any sequence near a 
PAM site, provided a guide specific to that sequence can be created [118]. This is the 
basis of CRISPR-Cas9 genomic editing: whereas double-stranded DNA breaks of viral 
targets within a bacteria will induce degradation of that target, double-stranded DNA 
breaks in an organism’s genome will often be repaired by the cell via ‘Non-homologous 
End Joining’ (NHEJ), and sequence mutations will be generated at these precise 
locations [119, 120]. Non-homologous end joining is a major repair pathway for DNA 
breaks in eukaryotic cells, and is flexible enough for eukaryotes to rely on when 
repairing DNA damage at most genomic loci [121]. However, this flexibility comes with 
a trade-off as this repair mechanism is also error prone and often leads to insertions 
and/or deletions at the cleavage site which may disrupt genomic sequences [122].  
When used to edit the genome of model organisms, the RNA constituents of CRISPR/Cas 
can be combined into a single construct called a synthetic guide RNA (sgRNA) [123, 
124]. This sgRNA consists of a 20-21 nucleotide long sequence homologous to the 
target, followed by an ‘NGG’ PAM site and a tracrRNA scaffold. These sgRNAs can be 
designed and ordered easily using web tools such as CHOPCHOP [125]. The sgRNA is co-
injected with mRNA encoding the Cas9 gene, or the Cas9 protein, into the embryo of the 
target organism shortly after fertilization. This technology has previously been applied 
to Xenopus with high levels of success and introduction of the Cas9 protein has been 
shown not to produce deleterious effects [126]. CRISPR/Cas genome editing represents 
the cutting edge of modern genetic research techniques. When combined with the 
background knowledge and theory outlined here, it forms the foundation on which this 




Aim and objectives 
 
The aim of this project was to further our understanding of this fascinating link between 
skin microbiome and tail regeneration in Xenopus laevis tadpoles. This was achieved 
through a two-pronged approach wherein both sides of the skin microbiome-
regeneration equation were interrogated. The first objective was to achieve a 
CRISPR/Cas9 knockdown of tlr4 in X. laevis to impair the tadpole’s ability to recognise 
gram-negative bacteria. In theory, this would hamper the immune response following 
tail amputation and reduce regenerative success. The second objective was to stimulate 
a Tlr4 mediated immune response via exogenous application of LPS to gentamicin 
treated tadpoles immediately after tail amputation. This included the LPS of gram-
negative bacteria known to be present in the skin microbiome of X. laevis, and would 
theoretically rescue the poor regeneration observed following gentamicin treatment. 
Approaching the question from both sides, these two experimental avenues shed light 















Materials and Methods 
 
Materials: 
Chemicals, reagents, and kits      Catalogue ID 
1kb Plus DNA Ladder from Invitrogen      10787018 
30% Acrylamide/Bis from BioRad      1610158 
APS (10% w/v made fresh daily) 
Chelex 100 Resin from BioRad      1432832 
Chloroform from Sigma        02487 
Coomassie Brilliant Blue R-250 from Sigma     B6529 
L-Cysteine hydrochloride from Sigma     C7477 
DNase I from Roche        04536282001 
100% Ethanol from VWR       1010600 
ExoSAP-it from Thermo Fisher       78200.200.UL 
Ficoll from Sigma        F4375 
Gentamicin sulfate from Sigma       G1914 
LB Agar from Fisher BioReagents      BP9723-500 
LB Broth from Fisher BioReagents      BP9723-500 
Lipopolysaccharide from E. coli O55:B5 from Sigma   L2880  
Lipopolysaccharide from R. sphaeroides from Invitrogen   tlrl-prslps 
Magnesium Chloride from J. T. Baker     FW203.30 
MS222 from Sigma        A5040-250G 




NEB buffer 2 from New England BioLabs      B7002S 
Noble agar from Sigma       A5432 
NOVEX Sharp Unstained Protein Standard from Thermo Fisher  LC5801 
Paraffin oil from Pharmacy Health      LA0200PLP 
Phenol chloroform from Sigma      77617-100ML 
Pierce Silver Stain Kit from Thermo Fisher    24612 
Protein Kinase K from New England BioLabs    P8107S 
Purple Loading Dye (6x) from New England BioLabs    B7024S 
sgRNA Synthesis Kit, S. pyogenes from EnGen     E3322V 
SpyCas9 NLS from EnGen        M0646T 
T7 Endonuclease Kit from New England BioLabs     E3321 
TRI reagent from Sigma       93289-100ML 














Solutions used in X. laevis embryo and tadpole culturing 
Cystine hydrochloride 
2% w/v in 1x MMR. Adjusted to pH 7.9 
Ficoll (type 400) 
6% or 3% w/v in 1x MMR 
10 x MMR (Marc’s Modified Ringer’s solution) 
1M NaCl, 20mM KCl, 10mM MgSO4.7H2O, 20mM CaCl2.2H2O, 50mM HEPES, 1mM EDTA, 
pH8.0 
 
Solutions used in DNA extraction, PCR, and processing 
NEB buffer 2 
50mM NaCl, 10mM Tris-HCl, 10mM MgCl2, 1mM DTT, pH 7.9 
TE buffer 















Software         Version 
 
Biorender          
CHOPCHOP         3 
DECODR         2.9 
Graphpad Prism        9.0.1 
inDelphi          
Inkscape         1.0.2 
Microsoft Excel        2019 
Microsoft Word        2019 
EnGen sgRNA Template Oligo Designer     1.12.1  
SnapGene         5.2.5 






2.1 CRISPR/Cas knockdown 
2.1.1 sgRNA selection 
The online tool CHOPCHOP v3.0 [125], utilising the Xenopus laevis genome assembly 
v9.2, was used for the selection of sgRNAs targeting X. laevis tlr4 for CRISPR/Cas9 
deletion. The mRNA ID for tlr4 was entered into CHOPCHOP (rna23238), as it produced 
a greater selection of sgRNAs than the gene ID (tlr4.s). A total of 190 hypothetical 
sgRNAs were produced in a ranked list based on how well the CHOPCHOP algorithm 
predicted the each would perform. These rankings were made using aspects of the 
sgRNA such as GC content and self-complementarity, as well as predictions of aspects 
such as editing efficiency and frameshift frequency. Considering these rankings, and 
with particular focus on target location within the gene and predicted frameshift 
frequency, sgRNA rank 1, rank 2, rank 15, rank 23, rank 29, and rank 50 were selected. 
The target site of each selected sgRNA is presented in Figure 3.  
 
Figure 3: Schematic of the Xenopus laevis tlr4 gene. The location of the double stranded cut 
directed by each sgRNA has been approximated by the arrows, and the Amino Acid (AA) at each 
cut site is listed with each sgRNA (relative to the whole tlr4 gene). ‘TIR’ stands for 
‘Toll/Interleukin-1 receptor’ and denotes the region correlating to the intracellular signalling 





2.1.2 sgRNA preparation  
These six sgRNAs sequences were entered into the EnGen sgRNA Oligo Designer v1.12.1 
to be converted into 55bp oligos which were then ordered from Integrated DNA 
Technologies. Sequences, relevant statistics, and final stock concentrations are 
presented in Appendix 1. The oligos were converted into mature sgRNAs using the 
EnGen Cas9 sgRNA kit, following the manufacturer’s instructions. This reaction was 
carried out in 0.2mL PCR tubes using the volumes listed in Table 1, which were mixed 
thoroughly and incubated in a hot block at 37°C for 30 minutes. 
 
Table 1: Volumes of reactants for sgRNA preparation using the EnGen Cas9 sgRNA kit. 
Reagent Amount (µL) 
Ultrapure Water 2  
EnGen 2x sgRNA Reaction Mix 10  
55bp DNA Oligo (1µM) 5  
DTT (0.1M) 1  
EnGen sgRNA Enzyme Mix 2  
Total Volume 20  
 
The proceeding steps were carried out on ice. Total volume was brought up to 50µL by 
the addition of ultrapure water before the addition of 2µL DNase I (provided in the kit) 
and further incubation in a hot block at 37°C for 15 minutes. A 2.5µL volume of each 
sgRNA was set aside following this step for assessment via 3% agarose gel 
electrophoresis under denaturing conditions as recommended by the manufacturer 
(not shown). All six sgRNAs produced the expected results following this assessment, 
clearing them for further purification.  
2.1.3 sgRNA purification 
The sgRNA preparations were transferred to a clean 1.5mL Microcentrifuge tube and 
made up to a volume of 300µL via the addition of 222.5µL of ultrapure water and 30µL 
of ammonium acetate. Next, 300µL of 4°C phenol chloroform was added, and the tubes 
were vortexed for 30 seconds to mix before centrifugation at top speed for five minutes. 




tube. To this tube, 300µL of isopropanol was added before vortexing for 30 seconds, 
followed by incubation for 30 minutes in a -20°C freezer to precipitate the sgRNA. The 
tubes were then centrifuged at full speed for 30 minutes at a temperature of 4°C. The 
supernatant was decanted, and the resulting RNA pellet was air-dried by leaving the 
tube open in a hot block at 37°C for five minutes. The dry pellet was resuspended in 
30µL of ultrapure water and separated into 2µL aliquots for storage in a -80°C freezer, 
to avoid freeze-thawing the sgRNA stock. One aliquot was taken from each sgRNA 
preparation to determine concentration via nanodrop spectrophotometry (Appendix 
1).  
2.1.4 sgRNA working dilutions for microinjecting 
As the optimum working concentration can vary between individual sgRNAs, the sgRNA 
stock aliquots produced in the previous step were made into either a 1:3 or a 1:5 
working dilution for the early experiments of this project. These working dilutions were 
each made fresh prior to microinjection in a clean 0.2µL PCR tube using the volumes 
listed in Table 2. Each tube was incubated in a 37°C water bath for five minutes to allow 
the Cas9 protein to associate with the sgRNA component prior to injecting. The Cas9 
utilised throughout this project was EnGen Spy Cas9 NLS (Product ID: M0646T) derived 
from Streptococcus pyogenes. (NLS stands for nuclear localization sequence, for targeted 
delivery to the nucleus). 
 
Table 2: sgRNA working dilutions for microinjection. 
Working 
Dilution 






Total Volume   
(µL) 
1:3 1.0 1.7 0.3 3.0 
1:5 0.6 2.1 0.3 3.0 
Cas9 Control 0.0 2.7 0.3 3.0 
 
2.2 Fertilising and de-jellying of X. laevis eggs 
Adult female X. laevis frogs were induced for egg laying by injection of 500 units of 
human gonadotropin hormone per 75g of frog body weight. The eggs were transferred 




Sperm was collected from male frogs via dissection and removal of the testis, which 
were then carefully crushed and mixed into solution with 1mL of 1x MMR to be added 
to the Petri dish containing the eggs (50-60µL per dish). Eggs and sperm collection was 
carried out in accordance with ethics permission (AUP-19-01) and with approval by the 
University of Otago Animal Ethics Committee. After five minutes, water was added to 
the Petri dish to dilute the MMR and activate the sperm. Fertilisation was given 20-40 
minutes to occur, which could be visualised as the pigmented hemispheres rotating to 
the north pole of the embryo. A sperm entry point is often also visible under a 
microscope as a small black spot on the egg. After 40 minutes, or once a fertilisation rate 
of 70-80% was observed, as much liquid was removed from the Petri dish as possible, 
and the dish was refilled with Cysteine hydrochloride (2% at pH 7.9) to de-jelly the 
fertilised eggs. This process took approximately five minutes, with occasional swirling. 
Once de-jellied, the liquid was removed from the Petri dish and the embryos were 
rinsed three times with 1x MMR.  
2.3 Microinjection 
2.3.1 Microinjector preparation 
The microinjector utilised throughout this project was a Drummond Nanoject II, held in 
place by a MM3 Micromanipulator. A glass microinjector needle was filled with paraffin 
oil using a syringe before being inserted into the microinjector and the end clipped off 
using fine tipped forceps. A 1.5µL volume of the desired sgRNA dilution was pipetted 
onto the lid of a Petri dish. The tip of the needle was inserted into this sgRNA droplet 
and backfilled into the needle. 
2.3.2 Embryo preparation 
Microinjection of embryos was carried out in a small Petri dish lined with 2% Noble 
agar to a depth of roughly 4mm. A clean razor blade was used to carve two trenches into 
the agar, approximately 5mm x 40mm each, and the plate was filled with 6% Ficoll in 1x 
MMR. The Ficoll and high salt content are required to avoid the cellular contents leaking 
from the embryos following injection. The freshly fertilised eggs were visually inspected 
for selection of the healthiest looking individuals from each batch (uniform shape and 
size, hemisphere pigmentation, sperm entry point etc.). Selected embryos were 
transferred to the trenches of the Noble agar plate (25 per trench) and aligned against 




2.3.3 Microinjecting embryos 
Using the control handles, the needle of the microinjector was carefully positioned 
against one side of the embryo, so that the opposite side of the embryo was pushed 
against the wall of the agar trench for stability. The needle was then pierced through the 
membrane of embryo’s animal pole, with care taken not to pass completely though the 
embryo and out the other side. A volume of 9.2nL of sgRNA was then injected into the 
embryo, and the needle retracted. This process was repeated for all embryos. Once 
injected, the embryos were allowed to rest for two hours before being transferred to a 
Petri dish containing 3% Ficoll in 0.1x MMR for incubation overnight at 18°C. The 
number of embryos injected per experiment was dependant on fertilisation and death 
rate but was generally ~50 embryos injected with each sgRNA dilution, and ~50 
embryos injected with Cas9 only to serve as negative controls. Approximately 24 hours 
after injection, any cellular material protruding from the needle wound was snipped off 
with a pair of fine forceps and the embryos were transferred to large Petri dishes 
containing media dependant on the experiment being performed (generally 0.1x MMR). 
The embryos were checked roughly every two days and their media replaced if 
necessary. During these checks, dead embryos were removed and discarded, and 
surviving embryos were often spread out between multiple dishes to avoid 
developmental defects produced by over-crowding (aimed for a maximum of ~30 
tadpoles per dish). 
2.4 Regeneration assay 
2.4.1 Tail amputation for regeneration assay 
The embryos were raised until they had developed into stage 46 tadpoles, whereupon 
they were anaesthetised, and their tails were amputated for assessment of regeneration. 
Tadpoles with an obvious developmental defect or unhealthy phenotype were removed 
and not included in these regeneration assays. The rate of developmental defects was 
noted for both the sgRNA treated tadpoles and Cas control tadpoles, although no major 
difference between the two groups was apparent. The tadpoles were reversibly 
anaesthetised with MS222 (also called Tricaine) at a concentration of 1/4000 mixed 
with 0.1x MMR. Tail amputation was achieved using a sterile scalpel blade, with a single 
cut at 1/3 of the tail’s length from the tip. Following amputation, each tadpole was 




experiments were transferred to a 24 well plate and had their amputated tail 
transferred into a 0.2mL PCR tube. The 24 well plate and PCR tubes were labelled so 
that each tadpole could be matched to its tail for DNA analysis of CRISPR editing (see 
Methods 2.5.2 below). Tadpoles involved in gentamicin or LPS regeneration assays 
were transferred into Petri dishes with the appropriate media following tail 
amputation, and their tails were discarded (see Methods 2.6). The tadpoles were then 
moved back to the incubator at 18°C for a five-day regeneration period. 
2.4.2 Regeneration phenotype scoring 
To assess how well each tadpole had regenerated its tail, they were each put into one of 
four categories: full, partial good, partial bad, or none. These categories correspond to a 
regeneration score ranging from 3 – 0, where full = 3, and none = 0. A mean 
regeneration score was calculated for tadpoles which were cultured together within a 
single Petri dish over the regeneration period. This average regeneration score 
controlled for the shared microbial environment and subsequent impact on skin 
microbiome composition between these tadpoles. These Petri dish-average 
regeneration scores were used to calculate the overall average regeneration of each 
relevant tadpole group. An example from each category of tail regeneration is presented 





Figure 4: Examples of the four categories of regenerative success. The red arrows approximate the 
point of tail amputation and scale bars give size reference. (a.) Full regeneration phenotype, core 
tissue growth and symmetrical fins. (b.) Partial good regeneration phenotype, core tissues present 
but tail is short and bent slightly, only one fin regenerated. (c.) Partial bad regeneration 
phenotype, minimal regeneration with core tissues forming down the line of amputation. (d.) No 
regeneration phenotype, no core tissue growth, slight bulging of fins from the amputation line but 





Table 3: Description of the phenotype for each of the four categories of tail 
regeneration.  
 
2.5 CRISPR/Cas DNA Preparation  
2.5.1 Embryo DNA extraction 
For each CRISPR/Cas experiment, roughly eight sgRNA injected embryos and at least 
two Cas control embryos were selected at random for DNA extraction to assess the 
general extent of CRISPR/Cas9 editing. These DNA extractions was carried out ~24 
hours after injection and the remaining embryos were retained and incubated to allow 
for phenotype assessment once more developed. The selected embryos were 
transferred to a labelled 0.2mL PCR strip with one embryo per tube and as little liquid 
as possible transferred. To each tube, 150µL of Chelex (5% in TE buffer) and 1.5 µL of 
Protein Kinase K (20mg/mL) was added. The Chelex slurry was mixed well before 
pipetting using a magnetic stir bar and stirrer. The embryo and solution were then 
homogenised by pipetting up and down to break apart the embryo, after which the 
tubes were vortexed briefly to mix. The tubes were then incubated at 56°C in a heat 
block for at least four hours, followed by 95°C for five minutes to deactivate any 
Regenerative 
Outcome 




Formation of the core tissues – notochord, muscle etc. 




Some regrowth of core tissues.  
May be slightly bent or under formed. 
Fins tend to grow asymmetrically. 
2 
Partial Bad 
Largely unsuccessful regeneration.  
Poor growth of core tissues and fins. 
Core tissues may grow along the line of the cut.  
1 
None 
No growth of core tissues or fins. 






remaining Protein Kinase K. The extracted embryo DNA sample was contained in the 
resulting supernatant, ready for PCR amplification (Methods 2.5.3).  
2.5.2 Tail DNA extraction 
As stated earlier, the amputated tails of tadpoles involved in CRISPR/Cas experiments 
were saved and labelled. This allowed for assessment of CRISPR/Cas editing within each 
individual tadpole, which could then be compared with that tadpole’s regeneration 
score. To extract the DNA from the tails, 150µL of Chelex (10% in TE) was added to each 
PCR tube, along with 1.5µL of Protein Kinase K (20mg/mL). The tails were not 
homogenised, as the embryos were, but they were vortexed vigorously to mix before 
centrifuging to ensure the tail was embedded in the Chelex beads and not stuck in the 
lid. The tubes were then incubated in a hot block at 56°C overnight, or for at least 12 
hours. Following this, the extracted tail DNA sample was contained in the resulting 
supernatant, ready for PCR amplification as described below. 
2.5.3 PCR amplification of the sgRNA targeted region 
Alongside the sgRNAs, primers were ordered for Polymerase Chain Reaction (PCR) 
amplification of roughly 250bp encompassing the target site of each sgRNA. These 
primers were chosen based on recommendation by the CHOPCHOP algorithm regarding 
the possibility of off target binding, with no expected off targets for any primer pair 
utilised here. Primer sequences and statistics are presented in Appendix 2. The 
polymerase used for this PCR was MyTaq DNA polymerase which does not have 
proofreading function, although for small amplicons such as these this was not an issue. 
This PCR reaction was carried out in 0.2mL PCR strip tubes, using an Eppendorf 
Vapo.Protect Thermocycler and 20µL of the reaction mixture outlined in Table 4.  
 
Table 4: MyTaq PCR reaction mixture for amplification of the sgRNA targeted region.  
Reagent Volume (µL) 
Extracted DNA Supernatant 1.0  
MyTaq Buffer 5x (contains dNTPs) 4.0  
Forward Primer (10µM) 0.8  
Reverse Primer (10µM) 0.8  
Ultrapure Water 13.2  




The thermocycler program used for these PCR reactions is detailed in Table 5. A 
generic annealing temperature of 60°C is listed here, the real annealing temperature 
used was dependant on the specific primer pair (Appendix 2). 
 
Table 5: MyTaq PCR thermocycler program for amplification of the sgRNA targeted 
region. 
 
2.5.4 Non-sequence-based detection of CRISPR/Cas edits – T7 Endonuclease 
To quickly and cost effectively determine the presence or absence of CRISPR/Cas 
editing without having to sequence every DNA sample, a T7 Endonuclease I assay was 
utilised. The theory behind T7 Endonuclease detection of CRISP/Cas edits is outlined in 
Results 3.1.4. The reaction mixture for this assay was set up in a 0.2mL PCR tube by 
adding 10µL of MyTaq PCR product from the previous step to 1.5µL of NEB Buffer 2 
solution, and 1.5µL of ultrapure water. These reaction mixtures were then placed in a 
thermocycler and passed through a program of careful denaturing and annealing, as 
described in Table 6.  
 
Table 6: Denaturing and annealing program for T7 Endonuclease assay. 
Function Temperature (°C) Ramp Rate Time 
Initial Denaturing 95  5 minutes 
Annealing 
95 –> 85 




Hold 4  Hold 
 
Function Temperature (°C) Time  
Initial Denaturing  95 2 minutes  
Denaturing 95 30 seconds 
35 Cycles Primer Annealing 60 30 seconds 
Elongation 72 30 seconds 




Following denaturing and annealing of the PCR products, 2µL of T7 Endonuclease 
enzyme (diluted 1:10) was added to each tube before incubating at 37°C for 15 minutes. 
This T7 endonuclease product then underwent electrophoresis on 1% agarose gel to 
assess the level of editing in the DNA. A T7 Endonuclease positive control was included, 
using a 250bp long DNA amplicon in excess, and a second amplicon, identical to the first 
but with a known mismatch. This positive control was designed to be cut by T7 
Endonuclease into a 150bp long, and a 100bp long fragment upon a successful T7 
Endonuclease assay. Further analysis of any detected edits required the sequencing of 
the DNA samples. 
2.5.5 Cleaning MyTaq PCR DNA for sequencing – ExoSap-it 
In order to sequence the DNA obtained from MyTaq PCR, it first had to cleaned by 
destroying the primers and free nucleotides remaining in solution. In a clean 0.2mL PCR 
tube, 5µL of MyTaq PCR product was mixed with 2µL of ExoSap-it reagent before 
incubation at 37°C for 15 minutes, followed by 80°C for a further 15 minutes. The 
cleaned DNA samples were diluted to approximately 1ng/100bp PCR product size 
(roughly 100ng/100µL) and then sent with 3.2pm of the required reverse primer to the 
Otago University Department of Anatomy for Sanger Sequencing [127]. Due to the dyes 
in the ExoSap-it reagent, nanodrop spectrophotometry could not be used to determine 
sample DNA concentration after cleaning. To correctly dilute each sample, its 
concentration was subsequently inferred from the agarose gel electrophoresis of the 
PCR product by comparing the sample bands to the bands in the 1kb ladder (of known 
concentration Appendix 3). The DNA sequence traces returned allowed for the 
quantification and characterisation of any CRISPR/Cas derived edits. This process was 
carried out using free online software called  ‘Tracking of Indels by Decomposition’, or 
TIDE [128], a process which is described in detail in Results 3.1.5. 
2.6 Gentamicin and LPS regeneration assays 
2.6.1 Culturing X. laevis tadpoles in gentamicin antibiotic 
As previously discussed, X. laevis tadpoles that are raised in broad- spectrum antibiotics 
display less successful regeneration of an amputated tail. To support this, a batch of 
eggs were fertilised and de-jellied, as described above, before being separated into an 
untreated control group and a gentamicin treated group. These treatment groups were 




following fertilisation. The untreated controls were raised in 0.1x MMR, while the 
treated embryos were raised in 50µg gentamicin /mL 0.1x MMR. This was the standard 
gentamicin concentration used throughout each experiment in this project, unless 
otherwise stated. The embryos were incubated at 18°C and checked every 48 hours to 
remove dead or developmentally defective embryos, as described previously. 
Each Petri dish had its media refreshed 24 hours post-fertilisation, with the gentamicin 
treatment dishes refreshed again every subsequent 48-hours. The media of the 
untreated control group was changed as infrequently as possible and only when 
required, to preserve the natural skin microbiome on the tadpoles. All tadpoles were 
raised until developmental stage 46, upon which time a tail regeneration assay and 
regeneration scoring was performed on them as detailed above. This gentamicin assay 
was replicated two more times with the tadpoles of different mother frogs to strengthen 
the data and control for batch variation in regeneration. Special care was taken to use 
separate equipment for the control vs gentamicin treated groups, as transferal of 
antibiotics and/or bacteria between treatment groups or cohorts would affect the 
validity of the results.  
2.6.2 Lipopolysaccharide challenge assays 
To satisfy objective two and determine the effect of exogenous application of bacterial 
LPS on tail regeneration, a series of LPS challenge assays were carried out. In these 
experiments, embryos were separated into untreated control and gentamicin treated 
groups, as outlined above. Upon reaching stage 46 of development, these two groups of 
tadpoles were further separated into sub-groups depending on the experiment being 
carried out. The LPS selected for these experiments included a commercial source of 
Escherichia coli and Rhodobacter sphaeroides LPS, as well as in-lab extracts of LPS from 
E. coli and R. sphaeroides, and two as of yet unidentified species of the genera 
Chryseobacterium and Delftia, respectively. The selection of these bacteria for LPS 
challenge is elaborated upon further in Results 3.2, while the protocol of LPS extraction 
and preparation is described below. The LPS of R. sphaeroides is an antagonist to Tlr4, 
meaning it suppresses receptor activation. For this reason, R. sphaeroides LPS was 
applied to a sub-group of untreated control tadpoles to assess whether it triggered a 
reduction in regenerative success. The other forms of LPS analysed here are agonists to 




gentamicin treated tadpoles to assess whether they could rescue the poor regeneration 
of these antibiotic treated tadpoles. A sub-group of untreated and gentamicin treated 
tadpoles were kept as controls to record baseline regeneration scores.  
Anaesthetisation and tail amputation was carried out as per the protocol described 
above. Tail amputation was performed on 15 tadpoles at a time to minimise time 
between tail amputation and LPS treatment. Following amputation, each tadpole was 
quickly rinsed in fresh 0.1x MMR to wash off the MS222, before transferral into a single 
well of a 24 well plate. Any media transferred with the tadpoles was replaced with 
950µL of fresh 0.1x MMR, before 50µL of the required LPS solution (1mg/mL standard) 
was added to the well. The tadpoles were exposed to the LPS for one hour, before being 
removed from the well, rinsed in fresh 0.1x MMR and transferred to a Petri dish with 
0.1x MMR for a five-day regeneration period at 18°C. Untreated and gentamicin treated 
controls were subject to the same one-hour incubation in a 24 well plate to control for 
this experimental procedure, however no LPS was applied to them. Regeneration 
scoring was then carried out, as described above. 
2.7 LPS extractions 
2.7.1 Growing bacteria for LPS extraction 
Extracting the LPS from the bacteria selected for this project required growing bacterial 
stock. The Chryseobacterium, Delftia, and R. sphaeroides stocks were cultured by Dan 
Hudson in the University of Otago Microbiology Department and were supplied in the 
form of a heat-killed broth, while the E. coli stock was cultured in-house. First, some 
autoclaved LB broth was split into three flasks totalling a volume of 500mL. Each flask 
was inoculated with a sample of Top10 Competent E. coli from the University of Otago 
Zoology Department -80 freezer using a sterile loop. The inoculated broths were 
incubated at 37°C overnight on a shaker. Having turned cloudy overnight, the bacterial 
broth was then used to swab LB agar plates for incubation at 37°C overnight to confirm 
the viability of the E. coli. The bacterial broths were then heat-killed prior to LPS 
extraction. 
2.7.2 Heat-killing bacteria for LPS extraction 
The heat-killing process was carried out in-house for the E. coli broth. This process 




60 minutes. Every 10 minutes the tubes were agitated. A sample from each tube was 
taken with a sterile loop and used to swab an LB agar plate, which were then incubated 
at 37°C overnight to confirm the bacteria had been successfully heat-killed. If colonies 
were present on the plate after incubation, then the heat-kill process was repeated until 
no colonies were observed after incubation. 
2.7.3 Lyophilising heat-killed bacteria 
The LPS extraction protocol calls for lyophilised (freeze dried) bacteria for accurate 
measurement by dry weight. The bacteria thus had to be washed, frozen and dried to a 
lyophilised powder. LPS extraction from a heat-killed bacterial broth required splitting 
the broth between six 50 mL tubes and centrifuging at 5000g for 10 minutes at 18°C in a 
Sorvall Evolution RC Centrifuge using a Fiberlite F14-6x250 rotor. The supernatant was 
then poured off the resulting bacterial pellets and discarded into a beaker. These pellets 
were then gently resuspended in their tubes using 10mL PBS pH7.2, before being 
combined into two tubes. These tubes were centrifuged at 5000g for 10 minutes at 18°C 
and the supernatant poured off into the discard beaker. The two resulting pellets were 
gently resuspended in 50 mL PBS pH7.2 before being centrifuged again at 5000g for 10 
minutes at 18°C. After discarding the supernatant into the discard beaker, the tubes 
were left inverted on a tissue to drain the remaining liquid off the pellets. These tubes 
were then placed into a -80°C freezer for at least two hours to freeze the bacteria 
pellets. Once well frozen, the two pellets were freeze dried in their tubes with the lids 
removed, using a VaO2 vacuum chamber at -80°C overnight.  
2.7.4 Extracting the LPS from lyophilised bacteria 
Now the bacteria had been lyophilised, the LPS could be extracted. The TRI reagent 
method was selected for this extraction due to the fast and convenient nature of the 
protocol [129]. First, 10mg of lyophilised bacteria was weighed out and added to a clean 
1.5mL tube (convenient to do multiple extractions at once). Then, 200µL of TRI reagent 
was added to the tube and vortexed vigorously to mix before incubation at room 
temperature for 10 minutes. Following this, 200µL of chloroform was added to the tube 
and it was vortexed vigorously to mix before another incubation at room temperature 
for 10 minutes, forming a phase separation. The tube was then centrifuged at 12000g 
for 10 minutes at 18°C and the aqueous phase (top layer) was carefully pipetted out and 




the aqueous phase was removed, as this aqueous phase contained the LPS. To maximise 
the yield of LPS, the organic phase (bottom layer) was washed three times with 
ultrapure water. This was achieved by adding 100µL of ultrapure water back to the tube 
containing the organic phase and vortexing vigorously to mix before incubation for 10 
minutes at room temperature and centrifugation at 12000g for 10 minutes at 18°C. The 
resulting aqueous phase was again carefully pipetted out and added to the tube with the 
aqueous phase from the previous step. This distilled water wash was repeated twice 
more. A 10µL portion of the resulting LPS solution was saved to assess the subsequent 
DNase, RNase, and proteinase cleaning phase of the experiment.  
2.8 Purifying and staining extracted LPS 
2.8.1 Cleaning the extracted LPS solution of DNA, RNA, and proteins 
To begin purifying the LPS extract, 1µL DNase and 1µL RNase was added to the LPS 
solution and mixed by flicking the tube. This was then incubated for 10 minutes at 37°C 
before 1µL Proteinase K was added to the tube and it was incubated for a further 10 
minutes at 37°C. This purification step was assessed by running 10µL of LPS solution 
from this step alongside the 10μL of LPS solution saved from the previous step on a 2% 
agarose gel electrophoresis with 2µL purple loading dye for each sample (example in 
Appendix 4). The LPS solution was then dried in an Eppendorf Concentrator Plus 
SpeedyVac for a minimum of seven hours to evaporate the chloroform from solution. 
2.8.2 Precipitating the extracted LPS 
To complete the LPS purification, each LPS pellet was resuspended and precipitated in a 
cold solution of magnesium chloride in ethanol, as per the procedure developed by 
Darveau et, al. [130]. Each dry LPS pellet was suspended in 500µL of cold 0.375M 
magnesium chloride in 95% ethanol, before vortexing to mix and incubation in a -30°C 
freezer for 30 minutes. Following incubation, the tubes were centrifuged at 12000g for 
15 minutes at 4°C and the supernatant was carefully pipetted out and set aside as a 
safety net. The tubes were then left inverted on a tissue for a few minutes to dry the 
resulting pellets of LPS. The purified LPS pellets were then each resuspended in 200µL 




2.8.3 Diluting and aliquoting the purified LPS extracts 
To avoid having to freeze-thaw a stock solution of LPS, each extract was diluted to a 
standard concentration and separated into 50µL aliquots. The desired final 
concentration of LPS applied to each tadpole was 50μg LPS/mL of 0.1x MMR (standard 
1x concentration). To achieve this concentration when the LPS was added as a 50µL 
aliquot to 950µL of 0.1x MMR as per the protocol, the standard concentration of LPS 
aliquot was 1mg/mL. 
The concentration of LPS within the 200µL solution produced after purification was 
inferred from the protocol, which states that a successful LPS extraction will yield 15-
20% of the starting dry weight of bacteria [129]. In hindsight, weighing the 1.5mL tube 
before and after the purification process would have improved the accuracy of these 
concentration estimations. The starting dry weight of bacteria was 10mg, resulting in a 
yield of roughly 2mg LPS suspended in 200µL of ultrapure water. This translates to a 
stock concentration of 10mg LPS/mL. The LPS dilutions were prepared immediately 
following extraction, according to the volumes outlined in Table 7. All LPS aliquots 
were stored in a -30°C freezer until required. These aliquots were easier to prepare in 
bulk, for example: 100µL of LPS stock solution could be added to 900µL of ultrapure 
water to produce 20 aliquots at the standard concentration of 1mg/mL. The 
commercially sourced LPS from E. coli and R. sphaeroides was also resuspended in 
ultrapure water, as per the manufacturer’s instructions, and similarly aliquoted at the 
standard concentration for storage in a -30°C freezer until required. 
 
Table 7: Required volumes for production of extracted LPS dilutions. 
LPS Concentration 
Being Produced 
LPS Stock Solution 
(10mg/mL) (µL) 
Ultrapure Water   
(µL) 
Total Volume Per 
Aliquot (µL) 
1mg/mL (standard) 5 45 50 
5mg/mL (5x) 25 25 50 





2.8.4 LPS silver stain and Coomassie Brilliant Blue stain 
To visualise the LPS extracts and as a check to ensure extraction process was successful, 
a portion of each LPS sample was run through acrylamide gel electrophoresis before 
being silver stained using a Pierce Silver Stain Kit from Thermoscientific, as dictated by 
the manufacturer’s instructions. This silver staining protocol for LPS detection is an 
adaptation of the sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-
PAGE) method of separating proteins by molecular mass [131]. For each gel that was 
silver stained for LPS detection, a second gel was loaded with identical samples and 
stained with Coomassie Brilliant Blue stain to check for protein contamination. Thus, 
two identical 0.75mm acrylamide gels were prepared simultaneously for each silver 
stain experiment.  
2.8.5 Acrylamide gel preparation 
These electrophoresis experiments were carried out using a Mini-PROTEAN Tetra 
Vertical Electrophoresis Cell using hand cast acrylamide gels. To prepare these gels, the 
glass plates that the gels were to be cast into were first cleaned twice with 100% 
ethanol. A monomer solution of the desired gel percentage was prepared by mixing the 
reagents listed in Table 8, except for the 10% APS and TEMED. This monomer solution 
was degassed for 15 minutes before the addition of the 10% APS, then the TEMED, after 
which the solution was mixed and immediately cast into the glass plates secured within 
a casting tray. A small volume of water (~500μL) was added on top of the acrylamide 
and rocked back and forth to ensure a flat top surface to the resolving gel. Once set, this 
water was blotted off with a tissue and a 3% acrylamide stacking gel was prepared by 
mixing the reagent listed in Table 9, again, adding the 10% APS and TEMED only when 
ready to cast.  
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Table 9: Reagents used in preparation of the acrylamide stacking gel (for 5mL 
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This stacking gel was pipetted on top of the resolving gel until overflowing the glass 
plates, before a 10-well comb was inserted to create a tight seal with no bubbles. Whilst 
the stacking gels were setting, the LPS samples were prepared by adding 5μL of sample 
buffer to 15μL of each LPS sample and heating in a 95°C water bath for 10 minutes. The 
glass plates containing the gels were then removed from the casting tray and placed into 
the PAGE cassette before the inner chamber of the cassette was filled with 1% running 
buffer. The combs were carefully removed, and the exposed wells were flushed of 
unpolymerized acrylamide with 1% running buffer. Each gel was loaded with 5μL of 
Novex Sharp protein marker in the left most well, before 15μL of prepared LPS sample 
was loaded into each well, according to the desired loading plan for each experiment. 
The electrophoresis was run at 70V for two hours, or until the dye front approached the 
bottom of the gel. Both gels were then carefully removed from their glass plates with a 
plastic spatula and placed in a clean plastic container for the staining process. For both 
the silver staining and Coomassie Blue staining procedures, sufficient volumes of the 
staining reagents were applied to the gels, ensuring they were thoroughly covered, and 
the gels were gently shaken during incubation steps on a shaker.  
2.8.6 Silver staining – Pierce Silver Stain Kit 
Silver staining was carried out with a Pierce Silver Stain kit from Thermo Fisher 
(Catalogue # 24612), according to the manufacturer’s instructions. Each gel was washed 
twice in ultrapure water for five minutes per wash, before two fixation incubations in 
30% ethanol: 10% acetic acid solution for 15 minutes each. The gel was then washed 
twice in 10% ethanol for five minutes each, before another two washes in ultrapure 
water for five minutes each. During these washes, a Sensitiser Working Solution was 
prepared by mixing one part Silver Stain Sensitizer with 500 parts ultrapure water. The 




minute washes in ultrapure water. A Stain Working Solution was prepared by mixing 
one part Silver Stain Enhancer with 50 parts Silver Stain. The gel was incubated in this 
Stain Working Solution for 30 minutes, during which a Developer Working Solution was 
prepared by mixing one part Silver Stain Enhancer with 50 parts Silver Stain Developer. 
A 5% acetic acid Stop Solution was also prepared during this incubation, as the next 
steps in the protocol were very time sensitive. The gel was quickly washed with two 
changes of ultrapure water for 20 seconds each, which was immediately followed by the 
addition of the Developer Working Solution. Bands began to appear on the gel as early 
as a few seconds after addition of the Developer, which was left on the gel until the 
desired band intensity vs background staining was achieved (roughly 30-45 seconds). 
Upon the desired level of staining, the Developer Working Solution was quickly replaced 
with the prepared Stop Solution for a brief wash before it was replaced with fresh Stop 
Solution for a further 10-minute incubation. The silver-stained gel was then 
photographed and could be stored in the Stop Solution for as long as desired.  
2.8.7 Coomassie Brilliant Blue staining 
The identically loaded sister gel to the silver-stained gel was utilized to assess for 
protein contamination within the LPS extracts. Coomassie Brilliant Blue is a commonly 
used stain for the visualisation of proteins due to its sensitivity [132]. The specific dye 
used was Coomassie Brilliant Blue R-250 from Sigma (Product ID: B6529) and staining 
was carried out at the standard concentration of 0.5% (w/v) for one hour with gentle 















3.1 Objective one: CRISPR/Cas9 knockdown of tlr4 
The skin microbiome of Xenopus laevis tadpoles has a powerful influence over tail 
regeneration. Culturing in antibiotics causes a notable decline in the number of tadpoles 
which successfully regenerate a severed tail [1]. We hypothesised that innate immune 
cells are exposed to gram-negative bacteria from the skin microbiome following tail 
amputation, causing an immune response that culminates in tail regeneration. Without 
this immune response, wound healing occurs at the cut site and the tail does not 
regenerate. In testing this hypothesis, the first objective was to remove the tadpole’s 
ability to recognise gram-negative bacteria through targeted knockdown of Toll-like 
receptor 4 (Tlr4), a key innate immune receptor. This was achieved through 
CRISPR/Cas9 directed editing of the tlr4 gene at the embryonic stage of development 
and assessed through tail regeneration assays.  
CRISPR/Cas9 is a powerful genetic engineering tool which allows unparalleled 
specificity of target selection thanks to a ‘synthetic guide RNA’ (sgRNA) with sequence 
homology to the desired target within the host genome. Guided by the sgRNA, a Cas9 
nuclease protein introduces a double-stranded DNA cut at a predictable location in the 
host genome. This DNA damage is repaired by the host, but this process is prone to 
errors which introduce insertions and/or deletions (InDels) of varying sizes at the cut 
site. These InDels are the desired outcome for CRISPR/Cas9 knockdown of tlr4, as they 
may disrupt the function of the protein after translation. Large insertions or deletions 
will affect multiple amino acids in the protein, potentially affecting protein folding, and 
InDels which change the reading frame of translation (called a frameshift) will affect 
every amino acid in the protein from that point on.  
Not all sgRNAs are created equal, the size and nature of edits and the efficiency at which 
they are produced is unique for each sgRNA. For the best chance of a successful 
knockdown experiment, multiple sgRNAs should be trialled to find the most effective. 
The online tool CHOPCHOP [125] was used to design six sgRNAs targeting different loci 




of the target gene and produces a large range of hypothetical sgRNAs targeting different 
loci within the gene. These sgRNAs are given a ranking by CHOPCHOP based on 
predictions on aspects such as editing efficiency, frameshift frequency, potential off 
targets, etc. The six sgRNAs designed for this project are referred to by their ranking as 
described by the CHOPCHOP algorithm throughout this thesis. This ranking should not 
be taken as an indication of performance and is purely for identification. 
3.1.1 Highly successful CRISPR/Cas9 editing with one sgRNA 
The editing potential of each of the six sgRNA was tested vigorously over multiple trials 
with tadpoles from multiple frogs. An overview of the experiments performed in this 
project is presented in Table 10. A major factor in the effectiveness of a sgRNA is its 
editing efficiency, which can by calculated by the online tool ‘Tracking of InDels by 
DEcomposition’, or TIDE [133]. Editing efficiency equates to the percentage of DNA 
strands in a sample that TIDE detects as being edited by the sgRNA directed Cas9. An 
arbitrary editing efficiency threshold of 10% was selected to denote generally 
successful editing by a sgRNA. The experiments in Table 10 are grouped in 
chronological order, where the coloured squares denote which sgRNAs were trialled in 
that experiment. A grey square indicates an editing efficiency detected by TIDE of <10% 
for that sgRNA, while a green square indicates an editing efficiency >10% by that 
sgRNA. sgRNA rank 15 surpassed this threshold in three separate experiments, the first, 
seventh, and eighth (mother frog β, L1, and M7 respectively). The other five sgRNAs did 
not reach this 10% editing efficiency threshold in any experiment. 
 
Table 10: Summary of each sgRNA injection performed in this project. 
Experimental Order 1st 2nd 3rd 4th 5th 6th 7th 8th 
 
Name of Mother β γ A1 H3 J1 K1 L1 M7 
sgRNA 
1         1 
2         2 
15         15 
23         23 
29         29 





After failing to detect an editing efficiency >10% in any experiment from the second 
through fifth, sgRNA rank 15 was reintroduced into the proceeding experiments to act 
as a positive control. When sgRNA rank 15 also failed to reach 10% editing efficiency in 
the sixth experiment, the experimental protocol was closely scrutinised. It was 
discovered that the SpyCas9 protein had passed its expiry date after the third 
experiment, and a fresh stock was promptly ordered. With fresh Cas9, sgRNA rank 15 
began producing high levels of DNA editing once again, thus each other sgRNA was 
trialled alongside it one more time. Even with sgRNA rank 15 as a de facto positive 
control, the other five sgRNAs still failed to reach 10% editing efficiency, indicating 
minimal DNA editing capabilities.  
Herein, sgRNA rank 15 will be the central focus of this analysis as the results it 
produced are the most relevant to the objectives of this project. That being considered, 
a full complement of data and results were collected for each trial of each sgRNA in this 
project. A sgRNA rank 2 T7 Endonuclease assay and TIDE analysis result will be 
presented in Appendix 5 to serve as an example of a sgRNA with minimal editing 
capabilities. The results produced by sgRNA rank 1, 2, 23, 29, and 50 were visually very 
similar, so for the sake of brevity only sgRNA rank 2 will serve this purpose.  
3.1.2 Using machine learning to predict the edits that sgRNA rank 15 would 
produce 
As previously stated, every sgRNA has a unique spectrum of edits that can only truly be 
identified through experimentation, however, the DNA repair mechanisms that are 
enacted at the cut site can offer some level of predictability. One method for predicting 
the outcomes produced by a sgRNA is to run it through a computational model called 
inDelphi [133]. inDelphi is a machine learning algorithm designed to predict the DNA 
repair outcomes at CRISPR-induced cut sites, therefore predicting the edits that the 
sgRNA will produce. inDelphi requires only 60bp of context sequence from before and 
after the sgRNA cut site to model the biological repair mechanisms that would take 
place if that cut were made in the DNA. The inDelphi prediction for tlr4 sgRNA rank 15 
editing is summarised in Figure 5.  
inDelphi predicted a -9bp deletion would be the most common edit produced by sgRNA 
rank 15 at a frequency of 37.8%, followed by a -7bp deletion at 12.2%, and a +1bp 




(<1%), except for a -19bp deletion which was predicted at a frequency of 2.7%. The 
predicted frameshift frequency of sgRNA rank 15 was 48.4%, which is toward the lower 
end of the spectrum regarding the frameshift frequency of an average sgRNA, as some of 
the more common edits (1-2bp InDels) would cause a change in frame. It is important to 
understand that inDelphi does not make predictions about a sgRNAs editing efficiency, 
it simply predicts the frequency of outcomes when hypothetical editing efficiency is 
100%. It should also be noted that the inDelphi model used to make these predictions 
was trained on mouse embryonic stem cells (mESC) and it is unknown how well 
inDelphi will generalise with the amphibian Xenopus laevis. A comparison between 
these inDelphi predictions and the real edits produced by sgRNA rank 15 was therefore 
of great interest.  
 
Figure 5: Screenshot of the inDelphi [133] predicted outcomes for sgRNA rank 15 editing. The 
green and blue colours of the +1bp insertion bar represent the proportion of each base (A,C,T,G) 
that make up that edit. The deletion bars are coloured depending on the predicted repair 
mechanism that causes that edit, either Microhomology End Joining (red) or Non-homologous End 
Joining (orange). 
 
3.1.3 Extracting and amplifying DNA from sgRNA rank 15 injected embryos 
To assess the editing by sgRNA rank 15, the DNA first needed to be extracted, and the 
targeted region amplified by PCR. To this end, a pair of primers were designed using 
CHOPCHOP concurrently with sgRNA selection, which would amplify a 221bp fraction 
of DNA around the target site (Appendix 2). Twenty-four hours post injection, a 
random selection of injected embryos had their DNA extracted with Chelex and 




This PCR product then underwent electrophoresis on a 1% agarose gel to confirm PCR 
amplification was successful. An example of a gel from the M7 cohort of rank 15 injected 
embryos is presented in Figure 6, where the PCR product is visible as a bright band at 
221bp in each sample. This indicates that the PCR was successful and that these primers 
have no off-target binding that would amplify the wrong target (often visible as bands of 
incorrect size). Included in every experiment was a group of embryos injected with Cas9 
but no sgRNA to act as a negative control. DNA from these Cas controls was also 
extracted and amplified with the sgRNA rank 15 primers to provide an example of a 
non-edited target region for comparison against the samples. 
 
Figure 6: Electrophoresis of DNA samples from the M7 embryo cohort following My Taq PCR on a 
1% Agarose gel. The contents of each lane are listed along the top, and the size of the relevant DNA 
marker bands are denoted on the left. Bands at 221bp indicate successful PCR amplification of the 
target region in all samples. 
 
3.1.4 Editing by sgRNA rank 15 detected by T7 Endonuclease assay  
T7 Endonuclease is an enzyme which will cleave double-stranded DNA in which one 
strand does not perfectly match the sequence of the other (called a heterodimer). By 
processing the PCR-amplified DNA samples through a carefully controlled program of 
denaturing and annealing, any samples that contain CRISPR/Cas derived InDels will 




these heterodimers and cleave the DNA, resulting in two DNA strands smaller in size 
than the original PCR amplicon. Sufficiently high levels of CRISPR/Cas editing by a 
sgRNA could thus be visualised via agarose gel electrophoresis as a pair of smaller 
bands in addition to the PCR amplicon of the sample.  
sgRNA rank15 was the only sgRNA that produced a level of editing high enough to be 
detected by T7 Endonuclease assay. Temporally, this was the first indication that sgRNA 
rank 15 was the only sgRNA capable of editing tlr4 to a high extent. An example of a gel 
from the M7 cohort of rank 15 injected embryos is presented in Figure 7. The primary 
band is of the expected length for the rank 15 primer pair at 221bp, denoted by ‘A’ in 
Figure 7. A secondary band is visible at ~150bp and a very faint tertiary band at ~70bp 
in each of the sgRNA rank 15 injected samples (denoted by ‘B’ and ‘C’ in Figure 7 
respectively), which is indicative of DNA editing in these samples. These extra bands 
were not produced by the Cas9 injected negative controls, supporting this claim. A 
250bp T7 Endonuclease positive control was included and was cleaved into fragments 
of 150bp and 100bp in length, indicating the T7 Endonuclease was performing as 
expected (Fig 7, right side).  
 
Figure 7: Electrophoresis of PCR product from the M7 embryo cohort following T7 Endonuclease 
assay on a 1% Agarose gel. The contents of each lane are listed along the top, and the size of the 
relevant DNA marker bands are denoted on the left. (A) The primary band at 221bp in all samples 
and controls represents the PCR product. Faint bands at (B) ~150bp and (C) ~70bp in the sgRNA 




3.1.5 Editing by sgRNA rank 15 confirmed by sequencing and TIDE analysis  
T7 Endonuclease can be used to quickly determine whether a DNA sample contains 
CRISPR/Cas derived edits, however this assay cannot be used to characterise these 
edits. Due to the nature of CRISPR/Cas, the edits produced by a single sgRNA can vary 
greatly, complicating their characterisation [134]. Fortunately, free online software 
such as ‘Tracking of Indels by Decomposition’, or TIDE [128] has been developed with 
this specific purpose in mind. The TIDE algorithm has been trained to use capillary 
sequence traces from an unedited control and the desired sample sequence to achieve 
characterisation of any edits present in the sample. Capillary sequencing, such as Sanger 
sequencing, produces a sequence trace in which different coloured peaks correspond to 
the specific nucleotide bases in the sequence. Many thousands of DNA strands are 
sequenced per sample to build these sequence traces. If an insertion or deletion is 
present in some, but not all DNA strands present in the sample, then the various InDels 
will cause misalignment of the DNA sequences. This can be observed in the sequence 
trace as overlapping of the different coloured peaks and a generally messy trace 
downstream of the sgRNA cut site. Using the sequence of the relevant sgRNA to predict 
the cut site, TIDE aligns the sample sequence to the unedited control sequence and 
decomposes the overlapping peaks to determine any offset. From here, TIDE can 
determine whether the offset is due to an insertion or a deletion, how large the InDel is, 
and at what frequency that particular edit is present in the sample.  
To characterise the edits produced by sgRNA rank 15, the PCR product of each control 
and sample were cleaned of free nucleotides and primers with ExoSAP-it and Sanger 
sequenced. An example of a Sanger sequence trace from an unedited control and a 
highly edited sample are presented in Figure 8. Clear indicators of editing in the sample 
sequence in Figure 8, b. include discrete peaks and clean sequence trace before the 
predicted cut site, followed by overlapping, messy sequence trace around and after the 





Figure 8: Example of Sanger Sequencing traces used for TIDE analysis. This example is the 
sequence trace from (a.) a Cas9-only injected control, and (b.) embryo #6 of the L1 cohort of 
embryonic samples injected with sgRNA rank 15. The target sequence for sgRNA rank 15 is 
enclosed by the large rectangle, and the adjacent NGG PAM site is enclosed by the smaller 
rectangle in the control sequence. The predicted cut site for sgRNA rank 15 is denoted by the 
vertical red line three base-pairs prior to the PAM site. These loci are again highlighted in the 
sample, although their sequences no longer match the control sequence due to DNA editing. The 
point at which the sequence trace degenerates due to editing is denoted by the red asterisk above 
the sample trace. 
 
TIDE was then utilised to align the sequence traces of each sample to a control sequence 
trace and decompose the overlapping peaks to characterise and quantify the edits 
present in the samples. An example of the results produced by TIDE analysis of the 
embryo with the highest editing efficiency achieved in this project is presented in 
Figure 9. TIDE results include a graph of the detected edits and the frequency at which 
they were detected in the sample (Fig 9, a). For each edit a p value is listed, where a 
value p<0.05 is deemed statistically significant (in this example, all detected edits were 
statistically significant). Also included in these results is a graph of the frequency of 
aberrant sequences, plotted against base pair location relative to the sgRNA cut site (Fig 
9, b). This can be thought of as an indicator of how much the sample sequence differs 
from the control sequence due to the offsets caused by InDels. In this example the 
frequency of aberrant sequences increases greatly immediately after the sgRNA rank 15 
cut site at 122 bp. The results obtained through TIDE analysis of each sample of the β, 





Figure 9: Example of the results produced by TIDE analysis of M7 embryo #8 injected with sgRNA 
rank 15, compared to a Cas9-only injected negative control. (a) Insertions and deletions detected 
by TIDE, graphed by InDel size (X-axis) against frequency of detection in the sample (Y-axis). (b) 
Frequency of aberrant sequences detected (Y-axis) plotted against base pair location relative to 
the sgRNA rank 15 cut site (X-axis), i.e. how much the sample sequence differs to the control 
sequence due to insertions and deletions caused by sgRNA rank 15. 
 
3.1.6 -7bp deletion and -9bp deletion: sgRNA rank 15’s favourite edits  
To uncover the full spectrum of sgRNA rank 15 edits, each of the three edited cohorts (β, 
L1, and M7) were first analysed separately. The frequency of each statistically 
significant edit across the embryos in a cohort was tabulated and is presented here in 




edit in these heatmaps allows editing level to be captured as cohort-wide editing 
efficiency.  
Chronologically first, the β Cohort experiment was carried out early in the project when 
multiple concentrations of sgRNA were being trialled to uncover the most effective 
concentration with minimal ill effects. As such, these results include two dilutions of 
sgRNA rank 15, a 1:3 and a 1:5 working dilution, with four injected samples for each, 
presented in Table 11 and Table 12, respectively. Sample two from the 1:3 dilution 
group did not produce a sequence trace that was clean enough for TIDE analysis and 
was thus left out of further analysis. 
Comparing the editing levels between the two dilutions, it became clear that the higher 
1:3 dilution of sgRNA would produce higher editing efficiency. The 1:5 dilution of sgRNA 
rank 15 had an average editing efficiency of 35.8% across the embryos of the β cohort, 
with 18.6% of these edits causing a frameshift (Table 12). The 1:3 dilution of sgRNA 
rank 15 more than doubled this editing efficiency, with an average of 76.1%, and 40.3% 
of these edits causing a frameshift (Table 11). This contributed to the decision to make 
1:3 the default working concentration of sgRNA throughout the rest of the project.  
The most common edits produced by sgRNA rank 15 are clearly indicated in Table 11, 
where two edits in particular were by far the most prevalent in the 1:3 dilution of the β 
cohort. The most common edit was a -9bp deletion at an average of 34.5%, while the 
second most common was a -7bp deletion at 34.3%. These results were promising for 
the inDelphi prediction of sgRNA rank 15 editing, as these two edits were predicted to 
be the most common. A comprehensive comparison between the inDelphi prediction 









Table 11: Summary of TIDE-detected edits caused by the 1:3 dilution of sgRNA rank 15 
in embryos of the β cohort. Edits are presented on a colour gradient from white (not 
detected) to dark green (frequency of 100%). Only statistically significant edits are 
presented (P<0.05), as determined by TIDE. Sample two is omitted due to poor 
sequence trace quality. 
 
 
Table 12: Summary of TIDE-detected edits caused by the 1:5 dilution of sgRNA rank 15 
in embryos of the β cohort. Edits are presented on a colour gradient from white (not 
detected) to dark green (frequency of 100%). Only statistically significant edits are 
presented (P<0.05), as determined by TIDE. 
 
 
The frequency of the edits detected in the embryos of the L1 cohort are summarised in 
Table 13. This cohort can be characterised as having high levels of DNA editing in five 
samples, and relatively lower levels of editing in the remaining three samples, bringing 
the cohort average of editing efficiency down to 40.8% at a frameshift frequency of 
24.3%. As with the β cohort, a -9bp and a -7bp deletion were the two most common edits 
detected, with the -7bp deletion now being the most common at a frequency of 17.9%, 






Sample -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 9 10 Shift
1 0 19.5 0 40.1 4.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 63.8 40.1
3 0 48.6 0 17.7 0 0 0 0 15.1 0 2.9 0 0 0 0 0 0 0 0 0 84.3 35.7
4 0 35.3 0 45.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80.3 45.0




Frequency of Edit (%)
β
1:5 Frame
Sample -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 9 10 Shift
5 0 6.9 0 22.8 0 0 0 0 0 0 0 0 0 5.9 0 0 0 0 8.7 0 44.3 28.7
6 0 5.8 0 5.7 0 0 0 0 0 0 7.5 0 7.0 0 11.7 0 0 0 0 0 37.7 24.9
7 0 18.3 6.6 4.8 0 0 0 0 0 9.5 0 0 0 0 0 0 0 0 3.8 0 43.0 20.9
8 0 18.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2 0.0
Average 0 12.3 1.7 8.3 0 0 0 0 0 2.4 1.9 0 1.8 1.5 2.9 0 0 0 3.1 0 35.8 18.6
Total
Frequency of Edit (%)




Table 13: Summary of TIDE-detected edits caused by the sgRNA rank 15 in embryos of 
the L1 cohort. Edits are presented on a colour gradient from white (not detected) to dark 
green (frequency of 100%). Only statistically significant edits are presented (P<0.05), as 
determined by TIDE. 
 
 
The last batch of embryos to be analysed were from the M7 cohort, summarised in Table 
14. High levels of editing were more consistent in this cohort than the L1 cohort, with 
average editing efficiency at 65.1% and a frameshift frequency of 34.4%. In agreement 
with the β and L1 cohorts, the -7bp and -9bp deletions were by far the most common edits 
detected in the M7 cohort. The -7bp deletion was the most commonly detected edit at a 
frequency of 26.8%, while the -9bp deletion had a frequency of 21.1%. 
 
Table 14: Summary of TIDE-detected edits caused by the sgRNA rank 15 in embryos of 
the M7 cohort. Edits are presented on a colour gradient from white (not detected) to dark 
green (frequency of 100%). Only statistically significant edits are presented (P<0.05), as 




Sample -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 9 10 Shift
1 0 0 0 30.8 0 0 7.0 0 0 0 0 0 0 0 0 0 0 0 0 0 37.8 37.8
2 0 0 0 0 14.0 0 33.4 0 0 0 0 0 0 0 5.4 0 0 0 0 0 52.8 38.8
3 0 3.2 0 11.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2 11.0
4 0 8.3 0 33.0 0 0 0 0 0 0 0 0 19.7 0 0 0 0 0 0 0 61.0 33.0
5 0 11.5 0 41.6 11.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 64.9 41.6
6 0 39.8 0 9.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 49.4 9.6
7 0 14.0 0 8.5 0 0 0 0 0 0 0 0 0 5.8 0 0 0 0 0 0 28.3 14.3
8 0 9.1 0 8.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7 8.6




Frequency of Edit (%)
Deletion (bp)
Frame
Sample -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 9 10 Shift
1 0 17.0 0 17.9 4.5 0 0 7.3 3.8 0 7.7 0 0 0 0 0 0 0 0 0 58.2 29.4
2 0 13.3 0 27.7 8.1 0 0 0 2.0 0 0 0 7.1 0 0 0 0 0 0 0 58.2 29.7
3 0 15.6 0 40.9 3.2 0 0 0 0 0 0 0 0 0 0 0 1.0 0 0 0 60.7 41.9
4 0 9.7 0 24.5 10.9 0 0 0 0 0 16.7 0 0 0 0 0 0 0 0 0 61.8 41.2
5 0 12.1 0 31.6 2.0 0 0 0 0 10.1 0 0 7.2 0 0 0 0 0 0 0 63.0 41.7
6 0 25.8 0 30.2 20.3 0 0 6.4 0 0 0 0 0 0.8 0 0 0 0 0 0 83.5 31.0
7 0 26.7 9.6 17.0 0 0 0 0 5.0 3.6 0 0 0 0 0 0 0 0 0 0 61.9 35.2
8 0 48.7 0 24.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 73.6 24.9
Average 0 21.1 1.2 26.8 6.1 0 0 1.7 1.4 1.7 3.1 0 1.8 0.1 0 0 0.1 0 0 0 65.1 34.4
Total







Until this point, detection of edits larger than 10bp in size had proven difficult in both 
the β and L1 cohorts. This was believed to be due to the PCR product being too small, 
making alignment of the control and sample sequences by TIDE difficult. To detect 
larger InDels, TIDE needed more of the sequence surrounding the cut site in order to 
align the sequences over a larger region. The embryos of the M7 cohort were thus PCR 
amplified using the sgRNA rank 15 reverse primer and the sgRNA rank 50 forward 
primer, resulting in a PCR product 1420bp long. Sequencing this larger region allowed 
TIDE to uncover some larger edits that may have otherwise been missed. Every M7 
embryo sample had at least one significant deletion larger than 10bp, however only two 
of these edits registered at a frequency greater than 1% in the M7 cohort average. These 
were a -19bp deletion at 5.2% and a -26bp deletion at 1.3%, both are included in Table 
15 where all deletions larger than 10bp are summarised. The -19bp deletion uncovered 
here is consequently the fourth most frequent edit detected in the M7 cohort and was 
successfully predicted by inDelphi to be the most common edit larger than 10bp.  
 
Table 15: Summary of TIDE-detected large deletions (-11bp to -30bp) produced by 
sgRNA rank 15 in embryos of the M7 cohort. Edits are presented on a colour gradient 
from white (not detected) to dark green (frequency of 100%). Only statistically 
significant edits are presented (P<0.05), as determined by TIDE.  
 
 
In general, insertions had thus far been less common than deletions in the previous 
cohorts and the M7 cohort was no different. Only three samples from the M7 embryo 
cohort had an insertion larger than 10bp in size that reached statistical significance, an 
11bp, 16bp, and 21bp insertion, respectively. These large insertions were low in 
Frame
Sample -30 -29 -28 -27 -26 -25 -24 -23 -22 -21 -20 -19 -18 -17 -16 -15 -14 -13 -12 -11 Shift
1 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0 1.4 1.4
2 0 0 0 0 10.1 0 1.1 0 0 0 0 11.1 0 0 0 0 0 0 0 0 22.3 21.2
3 0 0 0 0 0 0 0 0 0 0 0 8.2 0 0 0 0 0 0 0 0 8.2 8.2
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.8 0 0 0 0 0 2.8 2.8
5 0 0 0 0 0 0 0 0 0 0 1.1 3.3 0 0 0 0 0 0 0 0 4.4 4.4
6 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 1.7 1.7
7 0 0 0 0 0 0 0 0 0 0 0 4.9 0 0 0 0 0 0 0 0 4.9 4.9
8 0 0 0 0 0 0 0 0 4.1 0 0 10.9 0 0 0 0 0 0 0 0 15.0 15.0
Average 0 0 0 0 1.3 0 0.1 0 0.5 0 0.1 5.2 0 0 0.4 0 0 0 0 0 7.6 7.5
Total






frequency and each make up less than 1% of the combined editing by sgRNA rank 15 in 
the M7 embryo cohort. 
 
Table 16: Summary of TIDE-detected large insertions (11bp to 30bp) produced by 
sgRNA rank 15 in embryos of the M7 cohort. Edits are presented on a colour gradient 
from white (not detected) to dark green (frequency of 100%). Only statistically 
significant edits are presented (P<0.05), as determined by TIDE. 
 
 
The detection of these larger InDels increased the overall editing efficiency of the M7 
cohort to 73.6% and bumped the frameshift frequency up to 42.6%, as summarised in 
Table 17. Only the non-zero frequency edits are listed in Table 17, which means the 
range of insertion and deletion sizes displayed are not in linear order. The detection of 
these larger InDels and subsequent increase in the detected editing efficiency justifies the 
adaptation of the protocol to include a larger PCR fragment in future studies.  
 
Table 17: Combined summary of TIDE-detected large and small edits produced by sgRNA 
rank 15 in embryos of the M7 cohort. Edits are presented on a colour gradient from white 
(not detected) to dark green (frequency of 100%). Only non-zero frequency, statistically 




Sample 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Shift
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0 1.1 0
6 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.3 1.3
7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
8 4.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.6 4.6
Average 0.6 0 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0.9 0.7
Total




-26 -24 -22 -20 -19 -16 -9 -8 -7 -6 -3 -2 -1 1 3 4 7 11 16 21 Shift
Average 1.3 0.1 0.5 0.1 5.2 0.4 21.1 1.2 26.8 6.1 1.7 1.4 1.7 3.1 1.8 0.1 0.1 0.6 0.2 0.1 73.6 42.6
M7






3.1.7 Combined editing performance of sgRNA Rank 15 in embryos across all 
cohorts 
With an average for each cohort calculated, an overall performance record for sgRNA 
rank 15 in the embryos of this project could be formed and is presented in Table 18. In 
this heatmap, only the non-zero frequency edits are listed which means the changes in 
insertion and deletion size are not linear. The β cohort average used in Table 18 is that 
of the 1:3 dilution group, as this was the working dilution used for the other cohorts. 
Across all embryo samples sgRNA rank 15 produced an average editing efficiency of 
69.1%, at a frameshift frequency of 41.2%. The most common edit detected in all 
embryo samples was a -7bp deletion at a combined frequency of 26.3%. Second was a -
9bp deletion at 22.1% and third was a -19bp deletion at 5.2%, although it should be 
noted that data on edits larger than 10bp could only be collected from the M7 cohort.  
 
Table 18: Combined summary of TIDE-detected edits produced by sgRNA rank 15 across 
embryos of all cohorts. Edits are presented on a colour gradient from white (not detected) 
to dark green (frequency of 100%). Only non-zero frequency, statistically significant edits 
are presented (P<0.05), as determined by TIDE. 
 
 
3.1.8 Tail regeneration in sgRNA rank 15 edited tadpoles 
With the editing profile of sgRNA rank 15 established, the next step was to see whether 
the edits it produced in tlr4 would affect tail regeneration in X. laevis tadpoles. This was 
accomplished with a tail regeneration assay for the tadpoles of each of the previously 
mentioned cohorts. In a regeneration assay, sgRNA injected embryos, along with some 
untreated controls, were raised in Petri dishes and kept in an incubator to carefully 
control temperature. When X. laevis embryos have developed to stage 45 tadpoles, they 
enter what is known as a refractory period, in which the usually very reliable ability to 
regenerate a severed tail is greatly reduced, allowing for the effect of various treatments 
Frame
Cohort -26 -24 -22 -20 -19 -16 -9 -8 -7 -6 -4 -3 -2 -1 1 3 4 5 7 9 11 16 21 Shift
β 34.5 0 34.3 1.4 0 0 5.0 0 1.0 0 0 0 0 0 76.1 40.3
L1 10.7 0 17.9 3.2 5.1 0 0 0 0 2.5 0.7 0.7 0 0 40.8 24.3
M7 1.3 0.1 0.5 0.1 5.2 0.4 21.1 1.2 26.8 6.1 0 1.7 1.4 1.7 3.1 1.8 0.1 0 0.1 0 0.6 0.2 0.1 73.6 42.6
Average 1.3 0.1 0.5 0.1 5.2 0.4 22.1 0.4 26.3 3.6 1.7 0.6 2.1 0.6 1.3 1.4 0.3 0.2 0.0 0.0 0.6 0.2 0.1 69.1 41.2
Deletion (bp)
Total





on regenerative success to be studied [61]. This refractory period ends after stage 47, 
and tail regeneration is once again very reliable. For this reason, each regeneration 
assay was initiated right in the middle of the refractory period when the tadpoles had 
developed to stage 46, at which time a sterile scalpel blade was used to amputate the 
tail of each tadpole. The tadpoles were then incubated in their Petri dishes for a 
regeneration period of five days, after which they had their regeneration scored from 0 
(no regeneration) to 3 (full regeneration), as described in Methods 2.4.2. The number 
of tadpoles per Petri dish varied throughout the project due to availability of tadpoles 
and experimental scope, but ranged from roughly 15 tadpoles for smaller experiments, 
to 45 in larger experiments. A mean regeneration score was generated for each Petri 
dish and is represented by a point in a scatter plot of regenerative success. 
Following regeneration scoring, the results were graphed and analysed. For each 
cohort, a scatter plot of regenerative success was produced, allowing for visualisation of 
the impact each treatment had on regeneration. The regeneration scores for each 
treatment group were analysed by one-way ANOVA test and Tukey’s multiple 
comparisons test to determine statistical significance (P<0.05). In addition to each 
scatter plot, a stacked bar graph was produced presenting the proportion of each of the 
four categories of regeneration (full, partial good, partial bad, and none) observed 
within in each treatment group, along with the total number of tadpoles (n) per group. 
Regeneration was scored for the β cohort, however due to a high death rate and 
resulting small group size, those results are presented in Appendix 6.  
The results of the tail regeneration assay for the tadpoles of the L1 cohort are presented 
in Figure 10, where a total of 11 sgRNA rank 15 treated tadpoles survived to have their 
regeneration scored. An untreated control group and a gentamicin treated control 
group (GENT) were included to delineate baseline regeneration scores, along with a 
Cas9-only injected negative control group. Treating tadpoles of this cohort with 
gentamicin decreased their mean regeneration from 2.66 in the untreated group to 1.74 
in the gentamicin treated group, while mean regeneration in the Cas control group was 
similar to the untreated controls at 2.74. Although sgRNA rank 15 had the lowest 
regeneration score of the sgRNA injected groups at 2.46, the reduction in regenerative 
success relative to the untreated or Cas9 control groups did not reach statistical 





Figure 10: (Left) Scatterplot of tail regeneration scores for the tadpoles of the L1 cohort. Each 
data point represents the mean regeneration of the tadpoles within a single Petri dish. Where 
multiple Petri dishes of tadpoles are in the same treatment group, a combined mean regeneration 
score for that treatment is represented by a horizontal dash. Treatment groups are listed in the key 
to the right of the plot. Statistically significant differences in mean regeneration were determined 
by one-way ANOVA and Tukey’s multiple comparisons test and are denoted by an asterisk. (Right) 
Stacked graph displaying the proportion of each regenerative outcome scored in each treatment 
group. Each regenerative outcome is matched to its corresponding colour in the key at the bottom 
of the stacked graph. Regenerative outcomes include full (F), partial good (PG), partial bad (PB), 
and none (N), along with the number of tadpoles scored in each treatment group (n).  
 
A total of 30 sgRNA rank 15 treated tadpoles from M7 cohort survived to have their 
regeneration scored, as presented in Figure 11. Treating tadpoles of this cohort with 
gentamicin decreased their mean regeneration from 2.77 in the untreated group to 0.83 
in the gentamicin treated group. As with the L1 cohort, the Cas9 negative control group 
of the M7 cohort did not show a statistically significant decrease in regenerative success 
relative to the untreated controls. This indicates that the injection of the Cas9 protein 
into the embryos was not impacting regenerative success and affecting the results of the 
assay. The sgRNA rank 1, 2, and 23 treated groups similarly did not see a statistically 
significant drop in mean regeneration relative to the untreated group. However, mean 
regeneration in the sgRNA rank 15 treated group was reduced to 1.87 down from 2.40 






Figure 11: (Left) Scatterplot of tail regeneration scores for the tadpoles of the M7 cohort. Each 
data point represents the mean regeneration of the tadpoles within a single Petri dish. Where 
multiple Petri dishes of tadpoles are in the same treatment group, a combined mean regeneration 
score for that treatment is represented by a horizontal dash. Treatment groups are listed in the key 
to the right of the plot. Statistically significant differences in mean regeneration were determined 
by one-way ANOVA and Tukey’s multiple comparisons test and are denoted by an asterisk. Non-
significant differences in mean regeneration are labelled with ‘ns’ where appropriate. (Right) 
Stacked graph displaying the proportion of each regenerative outcome scored in each treatment 
group. Each regenerative outcome is matched to its corresponding colour in the key at the bottom 
of the stacked graph. Regenerative outcomes include full (F), partial good (PG), partial bad (PB), 
and none (N), along with the number of tadpoles scored in each treatment group (n). 
 
3.1.9 sgRNA rank 15 editing performance in the tadpoles of the L1, and M7 
cohorts 
The amputated tails of these tadpoles were not put to waste, as valuable DNA editing 
data could be gathered from them. DNA was extracted from the amputated tails to be 
sequenced and analysed by TIDE to work in conjunction with the regeneration data 
summarised above. As with the embryonic editing data, only the statistically significant 
edits are presented here (P<0.05).  
The editing performance of sgRNA rank 15 in the tadpoles of the L1 cohort is presented 
as a heatmap in Table 19. As this experiment was carried out before the adjustment in 
PCR protocol to uncover larger edit, only edits up to 10bp in size could be detected by 
TIDE. The most commonly detected edit in the L1 tadpole cohort was a -7bp deletion at 




a frequency of 15.9%. Overall, sgRNA rank15 had an editing efficiency of 41% and a 
frameshift frequency of 23.2% in the tadpoles of the L1 cohort.  
 
Table 19: Summary of TIDE-detected edits caused by the sgRNA rank 15 in tadpoles of 
the L1 cohort. Edits are presented on a colour gradient from white (not detected) to dark 
green (frequency of 100%). Only statistically significant edits are presented (P<0.05), as 
determined by TIDE. 
 
 
As was the case for the embryo samples, the tails of the M7 cohort were analysed for 
larger InDels, thus the heatmap of sgRNA rank 15 performance in Table 20 only 
presents the non-zero frequency edits detected in the M7 tadpole tail samples. The most 
commonly detected edit in the M7 tadpole cohort was a -9bp deletion at an average 
frequency of 14.4%, whilst the second most common was a -7bp deletion at a frequency 
of 13.1%. A -19bp deletion at a frequency of 1.42% was uncovered due to sequencing 
the larger PCR product, making it the fourth most common edit here, as it was in the M7 
embryo samples too. The overall editing in the M7 tadpole cohort was slightly lower 
than that of the L1 cohort with an editing efficiency of 34.2% and a frameshift frequency 
of 17.5%. Tadpole #22 from this group died during the regeneration period and thus 
was left out of the regeneration scoring in Figure 11, however DNA was still extracted 
from its tail to contribute to the editing efficiency calculation.  
 
Frame
Sample -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 9 10 Shift
1 0 15.3 0 41.6 5.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 61.9 41.6
2 0 26.3 0 14.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 40.5 14.2
3 8.0 17.3 0 15.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 40.7 23.4
4 0 9.2 0 41.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50.3 41.1
5 0 4.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.1 0
6 0 9.2 0 33.6 4.8 0 8.1 0 0 0 0 0 0 0 0 0 0 0 0 0 55.7 41.7
7 0 23.0 0 9.3 5.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 37.3 9.3
8 0 14.9 4.3 28.1 0 0 0 0 0 0 0 0 0 0 8.9 0 0 0 0 0 56.2 41.3
9 0 17.2 0 12.6 8.3 0 0 0 0 10.8 0 0 0 0 0 0 0 0 0 0 48.9 23.4
10 0 23.5 0 9.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 32.7 9.2
11 0 8.4 0 6.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6 6.2
12 0 21.9 0 19.7 0 0 7.0 0 0 0 0 0 0 0 0 0 0 0 0 0 48.6 26.7
Average 0.7 15.9 0.4 19.3 1.9 0 1.3 0 0 0.9 0 0 0 0 0.7 0 0 0 0 0 41.0 23.2







Table 20: Summary of TIDE-detected edits caused by the sgRNA rank 15 in tadpoles of 
the M7 cohort. Edits are presented on a colour gradient from white (not detected) to 
dark green (frequency of 100%). Only non-zero frequency, statistically significant edits 





Sample -19 -10 -9 -8 -7 -6 -4 -3 1 3 4 5 8 Shift
1 0 0 13.6 0 6.0 0 0 11.7 0 0 0 0 0 31.3 6.0
2 18.7 0 9.1 0 25.9 0 0 0 0 0 0 0 0 53.7 44.6
3 10.3 0 13.0 0 8.8 0 0 0 0 0 0 0 0 32.1 19.1
4 0 0 9.5 0 25.6 5.2 0 0 0 0 0 0 0 40.3 25.6
5 0 0 37.0 0 7.9 0 0 0 0 0 0 4.9 0 49.8 12.8
6 0 0 29.5 0 14.3 0 0 0 0 0 0 0 0 43.8 14.3
7 0 0 10.9 0 7.6 8.7 0 0 0 0 0 0 0 27.2 7.6
8 0 0 20.3 0 21.2 0 0 0 0 0 0 0 0 41.5 21.2
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
10 0 0 24.6 0 15.7 6.4 0 0 0 0 0 0 0 46.7 15.7
11 0 0 13.5 0 5.9 0 0 0 0 0 0 0 0 19.4 5.9
12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
13 0 0 14.3 0 20.2 8.9 0 0 0 0 0 0 0 43.4 20.2
14 0 0 20.8 0 17.1 6.8 0 0 0 0 0 0 0 44.7 17.1
15 0 4.1 20.9 7.1 22.8 0 0 0 0 0 0 0 0 54.9 34.0
16 0 0 15.6 0 9.7 0 0 0 0 0 0 0 0 25.3 9.7
17 0 0 8.5 0 17.4 0 5.4 0 0 0 0 0 0 31.3 22.8
18 0 0 11.3 24.9 19.6 0 0 0 12.7 3.0 0 0 0 71.5 57.2
19 13.7 0 8.4 0 11.5 0 0 0 0 0 0 0 0 33.6 25.2
20 0 0 15.5 0 6.6 0 0 0 0 0 0 0 0 22.1 6.6
21 0 0 13.7 0 14.0 11.6 0 0 0 0 0 0 0 39.3 14.0
22 0 0 9.1 0 0 0 0 0 0 0 0 0 0 9.1 0.0
23 0 4.1 10.8 0 32.3 0 0 0 0 0 0 0 0 47.2 36.4
24 0 0 8.0 0 22.9 0 0 0 0 0 0 0 0 30.9 22.9
26 0 0 9.5 0 9.9 0 0 0 0 0 5.9 0 0 25.3 15.8
27 0 0 15.0 0 12.3 0 0 0 0 0 0 0 0 27.3 12.3
28 0 0 9.8 0 6.5 0 0 0 0 0 0 0 11.2 27.5 17.7
29 0 0 20.1 4.0 16.1 4.7 0 0 0 0 0 0 0 44.9 20.1
30 0 2.9 21.3 0 8.0 0 0 0 0 0 0 2.7 0 34.9 13.6
31 0 0 19.1 0 7.0 0 0 0 0 0 0 0 0 26.1 7.0
Frame
-19 -10 -9 -8 -7 -6 -4 -3 1 3 4 5 8 Shift
1.4 0.4 14.4 1.2 13.1 1.7 0.2 0.4 0.4 0.1 0.2 0.3 0.4 34.2 17.5
Insertion (bp)Deletion (bp)
Average
Deletion (bp) Insertion (bp)
M7 Tad






Across the tadpoles of both the L1 and M7 cohorts, only two tadpoles did not have any 
significant edits and only two did not reach at least 10% editing efficiency. This outlines 
an impressive conversion rate between editing observed in the embryo samples to the 
tadpole samples. 
 
3.1.10 Combined editing performance of sgRNA rank 15 in tadpoles across all 
cohorts 
As with the embryo samples, a performance record for sgRNA rank 15 across all 
tadpoles of the L1 and M7 cohorts was next to be calculated and is presented as a 
heatmap in Table 21. This was calculated by combining the average editing 
performance within the L1 and M7 cohorts, and again, only the non-zero frequency 
edits are listed. In concordance with the embryonic data, a -7bp deletion was the most 
commonly detected edit within tadpole samples at a combined frequency of 16.2%, and 
a -9bp deletion was second at 15.1%. A -6bp deletion at 1.83% and a -19bp deletion at 
1.42% characterise the other two edits detected at a frequency greater than 1%. 
 
Table 21: Combined summary of TIDE-detected edits produced by sgRNA rank 15 across 
tadpoles of all cohorts. Edits are presented on a colour gradient from white (not detected) 
to dark green (frequency of 100%). Only non-zero frequency, statistically significant edits 
are presented (P<0.05), as determined by TIDE. 
 
 
3.1.11 Regeneration Vs. editing in the L1 and M7 cohorts 
With comprehensive data on both editing levels and regeneration for the tadpoles of the 
L1 and M7 cohorts, an indication as to the effect that tlr4 editing by sgRNA rank 15 had 
on regeneration could be gleaned. Figure 12 presents scatter plot graphs of 
regenerative outcome plotted against either editing efficiency, or frameshift frequency. 
Frame
Cohort -19 -10 -9 -8 -7 -6 -4 -3 -1 1 3 4 5 8 Shift
L1 0.7 15.9 0.4 19.3 1.9 1.3 0 0.9 0 0 0 0.7 0 41.0 23.2
M7 1.4 0.4 14.4 1.2 13.1 1.7 0.2 0.4 0 0.4 0.1 0.2 0.3 0.4 34.2 17.5
Average 1.4 0.5 15.1 0.8 16.2 1.8 0.7 0.2 0.5 0.2 0.1 0.1 0.5 0.2 38.3 21.1
Total
Tadpole
Frequency of Edit (%)




Each data point in these graphs represents a single tadpole, which were grouped by full, 
partial good, partial bad, or no regeneration scores. 
As every tadpole from the L1 cohort scored either full or partial bad for regeneration, no 
data for the partial good or no-regeneration outcomes was collected (Fig 12, a.). 
Comparing the mean editing efficiency between the full and partial bad regeneration 
outcomes with a one-way ANOVA and Tukey’s multiple comparisons test did not 
uncover a statistically significant difference. Similarly, no significant difference in the 
frameshift frequency between either regenerative outcome was present.  
More data points were available for the M7 cohort, and all four regeneration outcomes 
were represented (Fig 12, b.), although relatively few tadpoles scored a partial bad or 
did not regenerate at all. Tadpole #25 of the M7 cohort displayed no regeneration but 
did not produce a clean sequence trace that could be analysed by TIDE and was thus 
omitted here. As with the L1 cohort, any differences in editing efficiency or frameshift 
frequency between the regenerative outcomes did not reach statistical significance 
following one-way ANOVA and Tukey’s multiple comparisons testing. Together, these 
results suggest no obvious relationship between total or frameshift inducing editing by 





Figure 12: Scatter plot graphs of regenerative outcome plotted against either editing efficiency 
(left), or frameshift frequency (right). Each data point represents a single tadpole, which are 
grouped by the extent to which they regenerated their tail (regenerative outcome). These 
regenerative outcomes include full (F), partial good (PG), partial bad (PB), and none (N). Mean 
editing efficiency per regenerative outcome is represented by a horizontal dash. Statistical 
significance was tested by one-way ANOVA and Tukey’s multiple comparisons test, no statistically 





3.1.12 Objective one summary – tlr4 knockdown 
sgRNA rank 15 was able to successfully induce high levels of editing in the tlr4 gene of X. 
laevis embryos. This editing was detected in stage 46 tadpoles with phenotypically 
normal development. When observing the cohort-wide mean regeneration scores, 
sgRNA rank 15 treatment correlated with reduced regeneration relative to Cas9 control 
treatment, but this reduction was not to the extent of gentamicin treatment. When 
observing individual tadpoles, no correlation between total or frameshift inducing 
editing by sgRNA rank 15 and regenerative success was detected. 
3.2 Objective two: modulating Tlr4 with bacterial LPS 
If objective one was to knockdown Tlr4 in an attempt to remove it from the 
regeneration equation, then objective two is precisely the opposite. Rather than 
removing Tlr4, the aim of these experiments was to modulate Tlr4 activation using the 
specific ligand that it has evolved to recognise: Lipopolysaccharide, or LPS. A major 
advantage of X. laevis as a model organism is the labile nature of tail regeneration, 
where any given cohort of tadpoles will likely have individuals which do not 
successfully regenerate. This allows for both loss of function experiments, such as the 
Tlr4 knockdown, and rescue of function, as these LPS experiments aimed to achieve. 
Part of the background work that helped form our hypothesis was the discovery that 
gram-negative bacteria were overrepresented in the skin microbiome of tadpoles for 
which regeneration was successful compared to those where it was not [1]. LPS 
constitutes a major structural component of the outer membrane of gram-negative 
bacteria and is the ligand to Tlr4, thus it is a perfect candidate for a major role in X. 
laevis tail regeneration under our current hypothesis. To interrogate what role LPS may 
play in regeneration, a range of LPS extracts, acquired commercially and by extraction 
in-lab, were exogenously applied to X. laevis tadpoles immediately following tail 
amputation, and their resulting regeneration was scored via regeneration assay as 
outlined previously. 
Although overall structure is conserved between species, there is subtle variation 
between gram-negative bacteria in specific LPS structure and therefore effect on Tlr4. 
Four genera of gram-negative bacteria were selected for representation in this project. 
Escherichia, specifically Escherichia coli was selected due to its availability and because 




regeneration being interrogated here [1]. Both Chryseobacterium and Delftia were 
selected as they are commensal bacteria that were determined to be overrepresented in 
the skin microbiome of tadpoles that successfully regenerate compared to those that do 
not, as determined by the same background work that this thesis builds upon [3]. 
Species level identification has not yet been achieved for the Chryseobacterium or Delftia 
utilised here. Finally, Rhodobacter, specifically Rhodobacter sphaeroides was selected 
because the LPS produced by this gram-negative bacteria is a Tlr4 antagonist [98], and 
thus hypothetically reduces the innate immune response, therefore reducing 
regenerative success in X. laevis. 
A commercial source of purified LPS from E. coli and R. sphaeroides was trialled, as well 
as LPS that was extracted from bacterial broth of each of the four selected gram-
negative bacteria, as detailed in Methods 2.6. Extracting LPS in-lab saved time and a 
great deal of money and would allow for bacteria isolated directly from the skin 
microbiome of X. laevis to be interrogated. In fact, this was exactly how the 
Chryseobacterium was sourced for this project, while Delftia was purchased from 
Landcare and R. sphaeroides from DSMZ, while the E. coli was readily available in lab 
storage. To ensure extraction was successful and to assess the purity of the LPS extracts, 
a series of three acrylamide gel electrophoresis experiments were caried out, in which 
the LPS extracts were stained using a ‘Pierce Silver Stain Kit’ from ThermoFisher.  
3.2.1 Confirming successful LPS extraction via silver staining 
LPS produces complicated and varying banding patterns when silver stained and run on 
an acrylamide gel. LPS extracts are a mixture of LPS aggregates and the constituent 
parts of the LPS molecule. Aggregates of LPS have low electrophoretic migration and an 
apparent molecular mass of around 50-100 kilodalton (kDa) [135]. Rough-form LPS (R-
LPS) consists of just lipid A which is the fastest migrating component of LPS, often 
migrating near the dye front at an apparent molecular mass of ~10kDa [136]. So-called 
semi-rough LPS (SR-LPS) consists of lipid A and the core oligosaccharide(s) but lacks 
the O-antigen, giving it slower electrophoretic migration and a larger apparent 
molecular mass. Smooth-form LPS (S-LPS) consists of lipid A, the core, and the O-
antigen and has been shown to be a heterogeneous mixture of LPS molecules with 
various numbers of repeating oligosaccharide units in the O-antigen [136, 137]. For this 




number of repeating units present in the O-antigen. These are not strict categorisations, 
as the apparent molecular mass, electrophoretic migration speed, and number of bands 
produced will often vary greatly between LPS preparations [138].  
The first silver stain experiment included a portion of the LPS extracted from 
Chryseobacterium (LPS-CH), Delftia (LPS-DF), and R. sphaeroides (LPS-RS), as well as a 
commercial E. coli (LPS-EK) positive control and was run on a 10% acrylamide gel 
(Appendix 7A). Being the first attempt at this protocol, this first gel was slightly over 
developed, and the bottom of the image was clipped which removed the lipid A band 
from some samples. From this we learned to leave a one-well gap between samples and 
to be very careful during the developing stage of the protocol, as leaving the developing 
solution on the gel for only a few seconds too long would overdevelop the gel and ruin 
the results.  
The second silver stain, presented in Figure 13, included LPS extracted from E. coli 
(LPS-EK), Chryseobacterium (LPS-CH), and Delftia (LPS-DF), with a 10μg and a 1μg 
commercial E. coli (LPS-EK) positive control. These samples were run on a 10% 
acrylamide gel and a gap was left between each sample of LPS. The left most well was 
loaded with a Novex Sharp protein marker containing proteins of known size in kDa, 
labelled on the left of the gel, while the loading plan of LPS samples is labelled along the 
top of Figure 13. A faint banding patten around 60kDa in size is present in every 
sample, likely corresponding to LPS aggregates. The commercial LPS-EK positive 
controls produced ladderlike banding from 40-60kDa which were especially visible in 
the 10μg sample and strongly suggest that the commercial LPS-EK is smooth-type. 
Additionally, a strong band was produced at 20kDa and a another at 10kDa, around the 
suggested size of lipid A and the core oligosaccharide. The commercial and extracted 
LPS from E. coli were from two different bacterial strains, thus a slight difference in 
banding pattern was expected, however, the extent of the difference observed in these 
results was striking. The extracted LPS-EK sample produced a strong band ~35kDa in 
size, slightly larger than the expected size band of for rough-type LPS, possibly implying 
a semi-rough LPS type for this strain of E. coli. A band of the same size is barely visible 
in the LPS-CH sample. The LPS-DF sample also produced this band, along with a smaller 
band that migrated with the dye front, likely to be lipid A, and some ladderlike banding 





Figure 13: Electrophoresis of LPS extracts on a 10% acrylamide gel with silver staining. A Novex 
Sharp protein marker was loaded in the first well and the size of the protein bands are labelled on 
the left in kDa. The contents of each well are labelled along the top and a gap was left between 
each sample, denoted by “[ ]”.  
 
Part of the LPS extraction protocol was to remove protein contaminants with protein 
kinase K, as the specific interaction between LPS and Tlr4 may be overshadowed by the 
immunological effects that protein contamination may cause. To assess the purity of the 
LPS extracts, an identical set of samples were run on a 10% acrylamide gel and stained 
with Coomassie Brilliant Blue protein stain, presented in Figure 14. A very faint band is 
just visible at ~35kDa in the LPC-CH sample, corresponding exactly to the very faint 
band in the silver stain, suggesting a low level of protein contamination in the LPS-CH 
extract. Interestingly, this band was not present in the first Coomassie Blue stained gel, 
run concurrently with the first silver stain experiment (Appendix 7B). All other LPS 
samples returned a negative result for Coomassie Blue protein staining, indicating no 





Figure 14: Electrophoresis of LPS extracts on a 10% acrylamide gel with Coomassie Blue protein 
staining. A Novex Sharp protein marker was loaded in the first well and the size of the protein 
bands are labelled on the left in kDa. The contents of each well are labelled along the top and a gap 
was left between each sample, denoted by “[ ]”. 
 
The final silver stain, presented in Figure 15, included LPS extracted from R. 
sphaeroides (LPS-RS), Chryseobacterium (LPS-CH), and Delftia (LPS-DF), with a 10μg 
commercial E. coli (LPS-EK) positive control and was run on a 12% acrylamide gel. The 
increase to a 12% gel from 10% dramatically increased the clarity of the banding 
patterns produced in this gel. The banding patterns of the LPS-CH, LPS-DF and 
commercial LPS-EK samples were identical in nature to Figure 13, although much 
clearer, especially around the dye front which was allowed to run further in this gel. 
LPS-RS produced a banding pattern very similar to LPS-DF, with a strong band at 35kDa 
and at 15kDa, but it did not produce the laddering at ~40kDa. Similar to the extracted 
LPS-EK from Figure 13, this may indicate that LPS-RS is semi-rough, although it may 
also be explained by the differing structure of Lipid A in R. sphaeroides, which contains 
five fatty acids, compared to the six fatty acids expected in the Lipid A of the other 





Figure 15: Electrophoresis of LPS extracts on a 12% acrylamide gel with silver staining. A Novex 
Sharp protein marker was loaded in the first well and the size of the protein bands are labelled on 
the left in kDa. The contents of each well are labelled along the top and a gap was left between 
each sample, denoted by “[ ]”. 
 
3.2.2 The regeneration reducing effect of gentamicin  
Before any LPS was introduced in a regeneration assay, a series of three gentamicin 
assays were carried out to characterise the effect that gentamicin treatment has on tail 
regeneration in X. laevis tadpoles. The regeneration reducing effect that culturing in 
gentamicin has on these tadpoles forms the basis of this research, thus the inclusion of 
comprehensive data on this effect in a range of cohorts was of great importance. As 
outlined previously, a regeneration assay involves groups of tadpoles that are raised 
and treated in Petri dishes until developed to stage 46, when a sterile scalpel blade is 
used to amputate the tail. For these gentamicin assays the tadpoles were then rinsed 
and their media replaced before incubation for a five-day regeneration period. After 
this, their regeneration was scored from 0-3 as previously described, and the results 
were graphed as a scatter pot of mean regenerative success and a stacked bar graph of 





These gentamicin assays were carried out at a time before a rigorous naming system for 
the mother frogs was in place, thus the cohorts are simply numbered from one to three. 
Each of the three cohorts saw a significant decrease in regenerative success between the 
untreated and gentamicin treated groups. The decrease in mean regeneration was from 
2.26 in the untreated group to 0.42 in the gentamicin group for Frog 1, from 2.36 to 1.25 
in Frog 2, and from 2.58 to 1.63 for Frog 3. Frog 3 also included a group of tadpoles 
which were raised untreated in 0.1xMMR until tail amputation and then raised in the 
standard concentration of gentamicin (50μg/mL) for the duration of the regeneration 
period. This group was included to assess whether culturing in gentamicin prior to tail 
amputation was required to produce the reduced regeneration effect, or if it could be 
reproduced with gentamicin treatment post-amputation. Regeneration in this group 
was reduced to 2.31, a statistically significant decrease relative to the untreated group 
but a far smaller reduction in regenerative success compared to the group raised in 
gentamicin from the embryonic stage. This implies that to see the full extent of the effect 
that gentamicin treatment has on regeneration, the tadpoles must be cultured in 
gentamicin from the earliest developmental stage possible. The relative simplicity of 
these gentamicin assays allowed for the inclusion of many tadpoles per treatment 
group, improving statistical power. 
 
Figure 16: (Left) Scatterplot of tail regeneration scores for the tadpoles from three preliminary 
gentamicin assays. Each data point represents the mean regeneration of the tadpoles within a 
single Petri dish. Where multiple Petri dishes of tadpoles are in the same treatment group, a 
combined mean regeneration score for that treatment is represented by a horizontal dash. 
Treatment groups are listed in the key to the right of the plot. Statistically significant differences in 
mean regeneration were determined by one-way ANOVA and Tukey’s multiple comparisons test 




graph displaying the proportion of each regenerative outcome scored in each treatment group. 
Each regenerative outcome is matched to its corresponding colour in the key at the bottom of the 
stacked graph. Regenerative outcomes include full (F), partial good (PG), partial bad (PB), and 
none (N), along with the number of tadpoles scored in each treatment group (n). 
 
3.2.3 Modulating tail regeneration with commercial E. coli and R. sphaeroides 
LPS  
With the effect of gentamicin on tail regeneration well established, the next round of 
experimentation was designed to introduce exogenous LPS to the tadpoles immediately 
following tail amputation and measure the effect that each LPS type had on 
regeneration. The regeneration assays carried out in these experiments were largely 
identical to those outlined previously, with the addition of a one-hour incubation in a 
24-well plate with exogenous LPS immediately after tail amputation. The LPS from E. 
coli, Chryseobacterium, and Delftia was applied to tadpoles that had been raised in 
gentamicin to assess whether it could rescue the poor regeneration that the gentamicin 
treatment causes. The LPS from R. sphaeroides was applied to untreated tadpoles to 
assess whether it would lower regenerative success, as LPS-RS is a Tlr4 antagonist. An 
untreated control and gentamicin control group were also included for baseline 
regenerative scores. No LPS was applied to these control groups, however the tadpoles 
were given the one-hour incubation in a 24-well plate following tail amputation to 
control for potential effectors such as stress.  
The first of these LPS assays aimed to study the effect of the two commercially sourced 
LPS types, that of E. coli and R. sphaeroides. These LPS regeneration assays were carried 
out in two cohorts of tadpoles, as presented in Figure 17. The untreated control group 
from Frog 1 regenerated perfectly (Fig 17, a.) with a mean regeneration of 3.00. The 
addition of LPS-RS to untreated tadpoles lowered their mean regeneration to 2.56 but 
did not reach statistical significance (P=0.066). Gentamicin treated tadpoles from Frog 1 
had a mean regeneration of 2.36, which was increased to 2.73 with the addition of LPS-
EK, but once again did not reach statistical significance (P=0.120). 
The untreated controls of Frog 2 again showed strong regeneration with a mean 
regeneration of 2.89 (Fig 17, b.). LPS-RS treatment caused a minor reduction in mean 
regeneration to a score of 2.88. The gentamicin control group scored a mean 




received LPS-EK treatment (mean regeneration score was 2.88 for these two dishes). 
However, the other dish in this treatment group regenerated very poorly, lowering the 
official mean regeneration to 2.63. 
 
Figure 17: (Left) Scatterplot of tail regeneration scores for the tadpoles from (a.) Frog 1, and (b.) 
Frog 2 from the commercial LPS-EK and LPS-RS assays. Each data point represents the mean 
regeneration of the tadpoles within a single Petri dish. Where multiple Petri dishes of tadpoles are 
in the same treatment group, a combined mean regeneration score for that treatment is 
represented by a horizontal dash. Treatment groups are listed in the key to the right of the plot. 
Statistically significant differences in mean regeneration were determined by one-way ANOVA and 
Tukey’s multiple comparisons test and are denoted by an asterisk. (Right) Stacked graph 
displaying the proportion of each regenerative outcome scored in each treatment group. Each 
regenerative outcome is matched to its corresponding colour in the key at the bottom of the 
stacked graph. Regenerative outcomes include full (F), partial good (PG), partial bad (PB), and 




The commercial R. sphaeroides LPS was further assessed with another LPS regeneration 
assay using the tadpoles of third frog, the results from which are presented in Figure 
18. This assay included only the relevant untreated control group and LPS-RS treated 
group. Mean regeneration in the untreated control group was 2.99, which was lowered 
to 2.79 by the addition of LPS-RS, a decrease in mean regeneration which reached 
statistical significance (P=0.0125). 
 
Figure 18: (Left) Scatterplot of tail regeneration scores for the tadpoles of the third commercial 
LPS-RS assay. Each data point represents the mean regeneration of the tadpoles within a single 
Petri dish. Where multiple Petri dishes of tadpoles are in the same treatment group, a combined 
mean regeneration score for that treatment is represented by a horizontal dash. Treatment groups 
are listed in the key to the right of the plot. Statistically significant differences in mean 
regeneration were determined by one-way ANOVA and Tukey’s multiple comparisons test and are 
denoted by an asterisk. (Right) Stacked graph displaying the proportion of each regenerative 
outcome scored in each treatment group. Each regenerative outcome is matched to its 
corresponding colour in the key at the bottom of the stacked graph. Regenerative outcomes include 
full (F), partial good (PG), partial bad (PB), and none (N), along with the number of tadpoles 
scored in each treatment group (n). 
 
3.2.4 Extracted E. coli LPS rescues regeneration to the same extent as 
commercial E. coli LPS 
The first of the extracted LPS types to be tested was that of E. coli (LPS-EK), as the 
commercial LPS-EK trialled previously could be used as a comprehensive positive 




cohorts of tadpoles comprised these experiments, the first of which being those of Frog 
D3 (Fig 19, a.). The gentamicin control group scored a mean regeneration of 1.53, which 
was rescued by both the commercial LPS-EK control treatment and the extracted LPS-
EK treatment by a statistically significant margin. The mean regeneration of the 
extracted LPS-EK group was 2.59, better than the commercial LPS-EK group at 2.35 and 
better still than the untreated control group at 2.57, although not to a statistically 
significant level. 
Tadpoles from Frog D4 comprised the second cohort in this experiment (Fig 19, b.), in 
which the gentamicin control group scored a mean regeneration of 1.48. As with the D3 
cohort, both commercial and extracted LPS-EK groups had statistically significant 
improvements to this mean regeneration, with scores of 1.91 and 1.79, respectively. 
Neither LPS-EK treatment rescued regeneration back to the level of the untreated 
tadpoles which had a mean regeneration of 2.47. 
The extracted E. coli LPS performed as well as, or even better than the commercial 
control at rescuing the regeneration of gentamicin treated tadpoles across these 






Figure 19: (Left) Scatterplot of tail regeneration scores for the tadpoles of (a.) Frog D3 and (b.) 
Frog D4 following the extracted LPS-EK assay. Each data point represents the mean regeneration 
of the tadpoles within a single Petri dish. Where multiple Petri dishes of tadpoles are in the same 
treatment group, a combined mean regeneration score for that treatment is represented by a 
horizontal dash. Treatment groups are listed in the key to the right of the plot. Statistically 
significant differences in mean regeneration were determined by one-way ANOVA and Tukey’s 
multiple comparisons test and are denoted by an asterisk. Non-significant differences in mean 
regeneration are labelled with ‘ns’ where appropriate. (Right) Stacked graph displaying the 
proportion of each regenerative outcome scored in each treatment group. Each regenerative 
outcome is matched to its corresponding colour in the key at the bottom of the stacked graph. 
Regenerative outcomes include full (F), partial good (PG), partial bad (PB), and none (N), along 




3.2.5 Extracted Chryseobacterium LPS is as powerful as E. coli LPS at rescuing 
regeneration 
As stated earlier, the Chryseobacterium spp. in question here were commensal bacteria 
that were isolated directly from swabs of adult female X. laevis frogs and cultured for 
LPS extraction in-lab. Testing LPS directly from the skin microbiome of X. laevis was 
perhaps the most direct approach possible given the aim of this project, making these 
results of great interest. This experiment was carried out with the tadpoles of five 
different frogs with varying concentrations of extracted LPS-CH, as presented in Figure 
20. Commercial LPS-EK again served as the positive control, and untreated and 
gentamicin treated groups provided baseline regeneration scores.  
For all five cohorts, treatment with either commercial LPS-EK or extracted LPS-CH 
rescued regeneration of gentamicin treated tadpole to a statistically significant degree 
relative to the gentamicin control groups. For the tadpoles of frogs F4 and F7, this 
rescue was to the same extent, if not better than the regeneration of the untreated 
control group. Extracted LPS-CH was as effective as the LPS-EK positive control 
regarding this rescue of regeneration, even outperforming it in some instances. The 
standard concentration (50μg/mL), 5x concentration (250μg/mL), and 10x 
concentration (500μg/mL) of extracted LPS-CH were all very similar in ability to rescue 
regeneration, with no concentration being significantly better than the others. The 










Figure 20: (Left) Scatterplot of tail regeneration scores for the tadpoles of (a.) Frog 1, (b.) Frog F4, 
(c.) Frog F5, (d.) Frog F7, and (e.) Frog F9 following the extracted LPS-CH assays. Each data point 
represents the mean regeneration of the tadpoles within a single Petri dish. Where multiple Petri 
dishes of tadpoles are in the same treatment group, a combined mean regeneration score for that 
treatment is represented by a horizontal dash. Treatment groups are listed in the key to the right 
of the plot. Statistically significant differences in mean regeneration were determined by one-way 
ANOVA and Tukey’s multiple comparisons test and are denoted by an asterisk. Multiple asterisks 
denote highly significant differences in mean regeneration and non-significant differences in mean 
regeneration are labelled with ‘ns’ where appropriate. (Right) Stacked graph displaying the 
proportion of each regenerative outcome scored in each treatment group. Each regenerative 
outcome is matched to its corresponding colour in the key at the bottom of the stacked graph. 
Regenerative outcomes include full (F), partial good (PG), partial bad (PB), and none (N), along 





Table 22: Mean regeneration scores for the treatment groups of the extracted LPS-CH 
regeneration assays. 
Frog Untreated GENT 
˹   Commercial LPS-EK   ˺ ˹                Extracted LP-CH                 ˺      
50µg/mL      100µg/mL 50µg/mL   250µg/mL   500µg/mL 
1 2.08 1.25 1.65  1.62 1.75  
F4 2.48 1.50 2.42 2.34 2.48 2.38  
F5 1.59 0.81 1.06  1.25 1.13  
F7 1.41 0.76 1.37  1.33 1.36  
F9 2.39 1.28 2.18  1.96 2.13 1.93 
 
3.2.6 Extracted Delftia LPS refuses to be outshined by Chryseobacterium LPS 
Similar to Chryseobacterium, Delftia were overrepresented in the skin microbiome of 
successfully regenerating X. laevis [3]. For this reason, the effect of extracted Delftia LPS 
(LPS-DF) on regeneration was of great interest, especially in comparison with the 
extracted LPS-CH analysed previously. An LPS regeneration assay was carried out with 
three cohorts of tadpoles from frogs C2, C10, and C8, the results of which are presented 
in Figure 21.  
In the first of these assays (Fig 21, a.), gentamicin treated tadpoles of Frog C2 were 
treated with two concentrations of extracted LPS-DF, a standard 50μg/mL 
concentration and a 5x concentration of 250μg/mL. No significant difference in mean 
regeneration was recorded between these two concentrations. Also included in this 
assay was a trial of a 2x concentration of gentamicin at 100μg/mL, to test whether 
regeneration could be reduced even further relative to the untreated controls without 
impacting tadpole development. Doubling the concentration of gentamicin slightly 
reduced mean regeneration relative to the standard 50μg/mL concentration, but this 
difference was not statistically significant. No obvious impact on tadpole development 
by the double gentamicin concentration was noted, so it was used as the gentamicin 
control concentration for the next two assays of the extracted LPS-DF experiment.  
Across all three assays, treatment with extracted LPS-DF was as effective, or better than 
commercial LPS-EK treatment at rescuing the regeneration of gentamicin treated 




rescue regeneration in the tadpoles of Frog C10 but not C8, although these differences 
in mean regeneration were not statistically significant. Treatment with all LPS types 
was sufficient to rescue regeneration to the same level as the untreated control group in 
the C2 and C10 cohorts, while only extracted LPS-CH treatment rescued regeneration to 
this extent in the C8 cohort. The specific mean regeneration scores for the extracted 





Figure 21: (Left) Scatterplot of tail regeneration scores for the tadpoles of (a.) Frog C2, (b.) Frog 
C10, and (c.) Frog C8 following the extracted LPS-DF assays. Each data point represents the mean 




in the same treatment group, a combined mean regeneration score for that treatment is 
represented by a horizontal dash. Treatment groups are listed in the key to the right of the plot. 
Statistically significant differences in mean regeneration were determined by one-way ANOVA and 
Tukey’s multiple comparisons test and are denoted by an asterisk. Multiple asterisks denote highly 
significant differences in mean regeneration and non-significant differences in mean regeneration 
are labelled with ‘ns’ where appropriate. (Right) Stacked graph displaying the proportion of each 
regenerative outcome scored in each treatment group. Each regenerative outcome is matched to 
its corresponding colour in the key at the bottom of the stacked graph. Regenerative outcomes 
include full (F), partial good (PG), partial bad (PB), and none (N), along with the number of 
tadpoles scored in each treatment group (n). 
 
Table 23: Mean regeneration scores for the treatment groups of the extracted LPS-DF 
assays. 
Frog Untreated 
˹                GENT                ˺              
LPS-EK 
˹    Extracted LPS-DF    ˺    
LPS-CH 
50µg/mL 100µg/mL  50µg/mL    250µg/mL 
C2 2.37 1.67 1.44 2.34 2.33 2.20  
C8 2.23  1.57 2.43 2.36  2.21 
C10 2.00  1.43 1.77 1.733  2.12 
 
3.2.7 Extracted R. sphaeroides LPS lowers regenerative capabilities of X. laevis 
tadpoles 
The final LPS assay was with the Tlr4 antagonist R. sphaeroides LPS (LPS-RS) that was 
extracted in-lab. Buying this LPS commercially was very expensive and previous efforts 
with LPS-CH and LPS-DF had shown that extracted LPS performed as well or better than 
commercially available LPS. As with the commercial LPS-RS assays, treatment with 
extracted LPS-RS was carried out on tadpoles grown in 0.1x MMR with no gentamicin, 
as LPS-RS is expected have the opposite effect to the other LPS trialled here and lower 
regenerative success. The results of two LPS-RS regeneration assays performed with the 
tadpoles of Frog M7 and M8 are presented in Figure 22. A standard concentration of 
50μg/mL, a 5x concentration of 250μg/mL, and 10x concentration 500μg/mL of 
extracted LPS-RS were included in both assays. For consistency with previous 
experiments and for baseline regeneration scores, a gentamicin control group and 




The first of these assays was with the tadpoles from Frog M7 (Fig 22, a.) where the 
untreated control group had a mean regeneration score of 2.77. Treatment with LPS-RS 
reduced this mean regeneration to 2.48, 2.24, and 2.20 for the 1x, 5x, and 10x 
concentrations, respectively. The reduction in mean regeneration score produced by the 
5x concentration reached statistical significance when analysed by one-way ANOVA and 
Tukey’s multiple comparisons test, while the other two concentrations did not. 
Culturing these tadpoles in gentamicin resulted in a mean regeneration score of 0.83, 
significantly lower than all LPS treatment groups.  
The final regeneration assay performed for this project was with the tadpoles of Frog 
M8 (Fig 22, b.), where the untreated control group scored a mean regeneration of 2.82. 
Again, all three concentrations of extracted LPS-RS prompted a decrease in mean 
regeneration to 2.47, 1.94, and 2.13 for the 1x, 5x, and 10x concentrations, respectively. 
Only the standard 50μg/mL concentration failed to reach a statistical significance. The 
5x concentration of LPS-RS was especially impressive in its ability to reduce 
regenerative success, with a mean regeneration even lower than the gentamicin control 
group at 1.96. These results suggest that the addition of the Tlr4 antagonist LPS-RS to 
otherwise untreated tadpoles immediately after tail amputation does reduce 
regenerative success. They also support the theory of competition by LPS-RS against 
pathogenic LPS for binding to and activation of Tlr4, as the higher concentrations of 





Figure 22: (Left) Scatterplot of tail regeneration scores for the tadpoles of (a.) Frog M7 and (b.) 
Frog M8 following the extracted LPS-RS assays. Each data point represents the mean regeneration 
of the tadpoles within a single Petri dish. Where multiple Petri dishes of tadpoles are in the same 
treatment group, a combined mean regeneration score for that treatment is represented by a 
horizontal dash. Treatment groups are listed in the key to the right of the plot. Statistically 
significant differences in mean regeneration were determined by one-way ANOVA and Tukey’s 
multiple comparisons test and are denoted by an asterisk. Multiple asterisks denote highly 
significant differences in mean regeneration and non-significant differences in mean regeneration 
are labelled with ‘ns’ where appropriate. (Right) Stacked graph displaying the proportion of each 
regenerative outcome scored in each treatment group. Each regenerative outcome is matched to 
its corresponding colour in the key at the bottom of the stacked graph. Regenerative outcomes 
include full (F), partial good (PG), partial bad (PB), and none (N), along with the number of 




3.2.8 Objective two summary – LPS modulation of Tlr4 
Specific modulation of Tlr4 receptors in X. laevis tadpoles was achieved via exogenous 
application of various forms of purified LPS following amputation. The agonistic LPS of 
E. coli, Chryseobacterium, or Delftia was sufficient to rescue tail regeneration in tadpoles 
cultured in gentamicin, often to the extent observed in untreated controls. When 
untreated tadpoles were exposed to the antagonistic LPS of R. sphaeroides, a reduction 
in regenerative success was observed, with higher concentrations of LPS-RS treatment 






















4.1 CRISPR/Cas knockdown of tlr4 
4.1.1 Why was sgRNA rank 15 the only effective sgRNA? 
A total of six sgRNAs were designed and trialled for this project, but only one was able 
to edit tlr4 in X. laevis by a significant amount. DNA sequencing and TIDE analysis 
confirmed that sgRNA rank 15 alone produced an editing efficiency greater than the 
arbitrary threshold of 10%. Luckily, this successful editing was detected in the very first 
experiment of this project, however it was the failure of sgRNA rank 15 to effectively 
edit during the sixth experiment which brought to light a point of failure in the protocol 
that had gone undetected for a number of weeks. Shortly after the completion of the 
third experiment, in which sgRNA rank 23 and rank 50 were tested, the SpyCas9 protein 
stock used for these experiments passed its expiry date. The fourth, fifth, and sixth 
experiments subsequently failed to produce high levels of DNA editing, including by 
sgRNA rank 15, which prompted an overhaul of the experimental protocol and led to 
the discovery of the expired Cas9 protein. The introduction of a fresh stock of Cas9 
protein marked the return of significant sgRNA rank 15 editing in the seventh 
experiment, yet the editing efficiency of the two sgRNAs trialled concurrently, sgRNA 
rank 29 and rank 50, remained very low. Similarly, the eighth experiment retained 
successful editing by sgRNA rank 15 but saw very low editing efficiency for sgRNA rank 
1, rank 2, and rank 23, exhausting all five sgRNAs other than sgRNA rank 15. With 
sgRNA rank 15 to act as a positive control, it was concluded that the other sgRNAs were 
ineffective at editing tlr4 in X. laevis.  
Why did five out of six sgRNAs fail to effectively cause edits? Firstly, the Sanger 
sequences returned from every sample in this project contained precisely the expected 
target sequence for their respective sgRNAs. This means single nucleotide 
polymorphisms (SNPs) within the tlr4 sequence targeted by each of these sgRNAs can 
be ruled out as an explanation for their ineffective editing. Similarly, the decision to 
incubate the sgRNA and Cas9 protein to form a mature sgRNA-Cas9 complex prior to 




Cas9 protein, which has been shown to be affected by non-specific intracellular RNAs 
competing for Cas9 binding [141]. Another cause of defective sgRNAs frequently cited in 
the literature is the potential for off-target binding of the sgRNA-Cas9 complex, reducing 
the level of sgRNA-Cas9 available to edit the desired target [142]. However, this was 
considered during the selection of all six sgRNAs, as CHOPCHOP listed any potential 
sgRNA off-targets present in the Xenopus laevis genome v9.2. The most likely off-target 
site for sgRNA rank 29 and rank 50 contained two mismatches. For sgRNA rank 2, rank 
15, and rank 23, the most likely off-target contained three mismatches, while no off-
target site with three or fewer mismatched nucleotides was detected for sgRNA rank 1. 
The presence of multiple mismatched nucleotides between these sgRNAs and their most 
likely off-target greatly reduces the likelihood of off-target binding having a notable 
impact on editing performance at the on-target site. 
One potential cause of ineffectual sgRNA editing is the tendency of the Cas9 protein to 
remain bound to the target site after forming the double stranded DNA break, 
potentially disrupting the DNA repair machinery from reaching the cut site [143]. 
Interestingly, it was discovered that sgRNAs which target and bind to the template 
strand of the target DNA could be dislodged by RNA polymerase as it moved along the 
DNA, circumventing this issue, while sgRNAs that bind to the non-template strand (i.e., 
the coding strand) could not be dislodged by RNA polymerase in this fashion [144]. 
sgRNA rank 15 does target and bind to the template strand of tlr4, in theory, allowing 
the Cas9 to be dislodged by RNA polymerase as it transcribes the tlr4 gene, freeing the 
cut site and allowing DNA repair and subsequent NHEJ to take place. sgRNA rank 1, rank 
2 and rank 29 each target the non-template strand and thus their editing efficiencies 
may have been affected by this tendency of Cas9 to remain bound to the cut site. 
However, there are some compelling reasons to doubt this theory. The first (and 
perhaps most obvious) being the fact that sgRNA rank 23 and rank 50 also target the 
template strand and failed to efficiently cause edits. Studies involving X. laevis 
uncovered a histone chaperone named ‘Facilitates Chromatin Transcription’ (FACT) 
that dislodges Cas9 from the cut site in a strand-independent manner [145], further 
casting doubt on this being the defining characteristic of the deficient sgRNAs. 
Additionally, this single-turnover characteristic of Cas9 is more relevant when the DNA 
target is in excess, such as bacterial defence against viral infection, and less relevant 




sequence. Any impact this effect had on the editing efficiency of the ineffective sgRNAs 
was likely minimal and it was certainly not the only factor curtailing their potency.  
The main influence on editing efficiency as determined by many studies is the intrinsic 
potency of the sgRNA itself [146, 147]. One of the major factors determining the potency 
of an sgRNA is the site of the target sequence [148]. Highly potent sgRNAs tend to target 
a coding region of the gene as close to the transcription start site as possible to 
maximise the number of amino acids affected by a frameshift mutation, while avoiding 
targeting introns and untranslated regions. Genes often exhibit a specific pattern of 
effective target sites, which may be affected by local chromatin structure. However, 
these gene-specific target patterns can be hard to identify without a large-scale trial of 
many sgRNAs to determine the most optimal target site. Another important factor 
regarding sgRNA potency is the GC content of the sgRNA, where it has been shown that 
a GC content that is either too high or too low greatly reduces the potency of a sgRNA 
[149]. In general, a GC content between 40-70% is optimal – criteria which all six 
sgRNAs met. 
Although not deterministic for sgRNA potency, sgRNAs have been shown in the past to 
display a preference for certain nucleotides in specific locations within the sgRNA 20-
mer [150], as summarised in Figure 23. The two positions within a sgRNA with the 
highest correlation to specific nucleotides are the 20th position, with a preference 
towards Guanine and an aversion towards Cytosine, and the 16th position, with a 
preference towards Cytosine and an aversion towards Guanine. Almost poetically, 
sgRNA rank 15 contains both a Cytosine in position 20 and a Guanine in position 16, the 
two least favoured nucleotides for a sgRNA, thus nucleotide favourability alone cannot 





Figure 23: Nucleotide preferences at each position in a sgRNA 20-mer. (From Doench, J.G., et al. 
2014. [148], determined using Human and Mouse cells). 
 
In summary, sgRNA rank 15 targeted the template strand roughly halfway through the 
third exon of tlr4, the furthest downstream of the sgRNAs trialled in this project. It had a 
CG content of 50%, putting it within the expected range of a successful sgRNA, and 
contained the two most statistically disfavoured nucleotides in its sequence. No single 
explanation stated previously elevates sgRNA rank 15 above the others on paper, and a 
combination of all these factors provides the best explanation behind the success of 
sgRNA rank 15 and the failure of the other sgRNAs. In future, the ideal strategy for 
uncovering the best sgRNA(s) would be to develop a large-scale screen of sgRNAs 
targeting different loci within the tlr4 gene and assess the potency of each.  
4.1.2 sgRNA rank 15 editing: inDelphi predictions Vs. real life 
sgRNA rank 15 may have been the only working sgRNA in this project, but that only 
stands to make the data it generated more valuable. The editing efficiency of sgRNA 
rank 15 varied between individual tadpoles but adding together the frequencies of the 
statistically significant edits in the embryo cohorts gave an overall editing efficiency of 
69.1% (Table 18). Although, in reality the actual editing efficiency may be slightly 
higher when the non-statistically significant edits are included.  
Comparing the sgRNA rank 15 edits predicted by inDelphi to the real edits detected by 
TIDE, it becomes clear that the machine learning algorithm used to make these 
predictions was somewhat accurate overall. Figure 24 presents a summary of the 




comparisons, the real-world editing efficiency of sgRNA rank 15 had to be considered, 
as inDelphi assumes a 100% editing efficiency. To control for this, each edit is listed 
alongside its corresponding proportion of the entire catalogue of edits.   
For example: the -7bp deletion was detected at a frequency of 26.3%. The overall 
editing efficiency when only the edits detected at a frequency >1% are included was 
65%. Thus, the -7bp deletion makes up a 40.5% proportion of the edits detected at a 
frequency >1% (calculation: 26.3  65 x 100). 
Most edits were predicted at a frequency relatively similar to the true outcome, with 
notable exceptions being in the three edits predicted to occur most frequently. The -9bp 
deletion was the closest of these three edits to its real-world counterpart but was 
overestimated by 9.2%. Considering the large proportion of edits that this -9bp deletion 
made up, this was a relatively accurate prediction. The -7bp deletion produced the most 
striking discrepancy, being underestimated by 26.6%. This predicted outcome 
frequency was less than half of the true outcome, as the -7bp deletion was nearly always 
the most frequent edit produced. The +1bp insertion was greatly overestimated, 
predicted at a frequency of 13.4%, but only detected at a frequency of 2%, a greater 
than six-fold discrepancy. Other notable differences include the prediction of a -1bp, -
3bp, and -8bp deletion that were not detected at a frequency >1%, and the detection of a 
+3bp insertion and a -26bp deletion that were not predicted by inDelphi (at frequency 
>1%). Considering the cumulative frequencies of the frameshift inducing edits only, 
inDelphi predicted a frameshift frequency of 45.8%, notably lower than the real-world 
frameshift frequency of 58.3%. Despite these differences, paired t-testing uncovered a 
correlation coefficient r=0.73, indicating that the inDelphi prediction were not 
statistically significantly different to the real-world outcomes. Perhaps one reason for 
the disparity between the predicted and real outcomes is the previously mentioned fact 
that inDelphi was trained on mouse embryonic stem cells, which may have lowered the 


























Figure 14: sgRNA rank 15 edits predicted by inDelphi (blue) compared to the real-world edits 
detected by TIDE (red). Edits are graphed by the proportion they make up with a hypothetical 
editing efficiency of 100%. Only the edits predicted or detected at a frequency >1% are depicted.  
 
4.1.3 The most common edits produced by sgRNA rank 15, and their 
consequences for Tlr4 
The vast majority of all sgRNA rank 15 edits were comprised of just the top four most 
commonly occurring edits. Regardless of whether or not they were predicted ahead of 
time, these edits had real world implications that could be analysed. In decreasing order 
of frequency, the most common edits produced by sgRNA rank 15 were a -7bp deletion, 
a -9bp deletion, a -19bp deletion, and a -6bp deletion. Detailed analysis of these edits 
requires inspection of the nucleotide sequence at the sgRNA rank 15 target site, as 
presented in Figure 25. The -7bp most common deletion (Fig 25, a.) caused the 
removal of two amino acids and triggered a +1 frameshift which altered the amino acid 
sequence from that point onward, culminating in a premature stop codon in the 472nd 
amino acid position of exon three. This truncated the normally 841 amino acid long Tlr4 
protein by 281 amino acids, removing nearly an exact third of the protein’s length, 
including the complete removal of the TIR domain. The third most common edit, a -
19bp deletion (Fig 25, b.), removed six amino acids and also triggered a +1 frameshift, 
leading to the premature stop codon at amino acid position 468. This truncated the 




responsible for intracellular signalling by the Tlr4 receptor, thus its removal by either of 
these edits is sufficient to knock out Tlr4 function. Furthermore, proteins that exhibit a 
premature stop codon due to a frameshift are subject to elimination via Nonsense-
mediated mRNA Decay (NMD) [151], ensuring the protein is non-functional. 
The second most common -9bp deletion (Fig 25, c.) and the fourth most common -6bp 
deletion (Fig 25, d.) were not frameshift inducing edits, removing three amino acids 
and two amino acids from the tlr4 gene, respectively. These small non-frameshift 
inducing edits were less likely to knock out Tlr4 function, as proteins tend to tolerate 
the loss of a small number of amino acids wile conserving overall structural stability 
[152]. That being said, small non-frameshift deletions have been observed on occasion 
that greatly alter protein function. For instance, a three base-pair deletion in the Cystic 
Fibrosis Transmembrane Conductance Regulator gene (CFTR) is capable of causing the 
disease after which its gene is named [153]. Whether or not the two specific small 
deletions being discussed here are sufficient to knock out or hinder Tlr4 functionality 
remains to be seen.  
Although the cut site of sgRNA rank 15 is known to be three nucleotides before the PAM 
site, this does not indicate exactly which nucleotides were deleted as a result of NHEJ. 
The specific nucleotides that were deleted was determined by analysis with 
Deconvolution of Complex DNA Repair, or DECODR [154], software similar in nature to 
TIDE in that it can align control and sample sequences to determine the edits caused by 
a sgRNA. It became apparent that TIDE was superior to DECODR for aligning the 
sequences and detecting the edits produced during this project, hence its selection for 
that purpose. However, DECODR has the added function of determining the specific 
nucleotides affected by an edit, thus it was utilised to that end. In the relatively few 
samples that could be aligned by DECODR, the most commonly detected version of each 
of the four most common edits was selected and is presented in Figure 25 as the 





Figure 25: Schematic of the sgRNA rank 15 target site in tlr4, exon 3, including the three letter 
amino acid sequence, created with SnapGene. This schematic presents the tlr4 gene in 5’-3’ 
orientation, hence the sgRNA rank 15 model at the top in red is in reverse orientation. For each of 
the four most common edits, the unedited sequence (top) is presented with the sgRNA rank 15 
target site enclosed by the red brackets, and the specific nucleotides to be deleted by that edit 
highlighted in blue. The edited sequence (bottom) has these nucleotides removed, denoted by the 
blue line, allowing inspection of the downstream effect on amino acid sequence. 
 
sgRNA rank 15 was consistent across all cohorts, and between embryo and tadpole 
samples in the nature and frequency of the edits it produced. If time had permitted, an 
interesting follow up would have been to re-sequence the samples of the β and L1 
cohorts using a set of primers encompassing a larger area around the target site, as was 
done for the M7 cohort. This may have improved alignment by TIDE and strengthened 




4.1.4 The nuanced relationship between CRISPR/Cas editing and regeneration 
sgRNA rank 15 was highly successful at introducing DNA edits into X. laevis tlr4, yet no 
discernible correlation between editing level and regenerative success is present among 
the individual tadpole data of cohorts L1 and M7 (Figure 12). However, a relationship 
between editing level and regeneration seemed to become apparent when these cohorts 
were analysed cumulatively. Tadpoles injected with sgRNA rank 15 displayed a 
decrease in regenerative success relative to Cas control groups when captured as mean 
regeneration in Figures 10 and 11. The impact of the Tlr4 knockdown can thus be 
described as an emergent property of these tadpole cohorts, where a decrease in 
regenerative success can be observed across the whole cohort but is lost upon 
inspection of individual tadpoles. That being said the question remains: why does tlr4 
editing level not correlate to regenerative success at an individual level? 
There are multiple potential explanations for this discrepancy, first and foremost being 
editing efficiency. The overall editing efficiency of sgRNA rank 15 was 69.1% (Table 
18), meaning that in all DNA strands sequenced, on average 69.1% of these were edited 
and the rest were not. This delineates a major challenge when trying to knockout a gene 
with CRISPR/Cas9 in the span of one generation: the mosaic effect of CRISPR editing 
[155]. Mosaicism is dependent on the species, the gene being targeted, and the target 
site of the sgRNA [156], and refers to the range of edits caused by CRISPR/Cas9 
resulting in a single organism harbouring multiple genotypes at once [157]. Some cells 
will have fully intact target genes, some will have no functional copy of the gene, and 
some will be heterozygous with a combination of both. Factor into this dilemma that 
some edits are less likely than others to knockout function of the target gene and the 
issue compounds. But even if every produced edit reliably knocked out gene function, 
the difficulty of mosaicism would remain due to unedited copies of the gene. It is for 
these reasons that this project is more accurately described as a tlr4 knockdown rather 
than a full knockout. 
A number of experimental procedures utilised throughout this project have been shown 
to be effective at limiting the mosaic effect of CRISPR/Cas9 editing. For instance, 
injecting the sgRNA-Cas9 protein complex directly into the embryo rather than 
introducing it in the form of an RNA plasmid has been shown to reduce the mosaic effect 




simultaneously targeting a gene with two different sgRNAs to reduce the chances of any 
unedited version of the gene escaping and to reliably cause very large deletions within 
the gene [159]. However, the most reliable method for reducing CRISPR mosaicism is to 
breed it out of the founding generation [160], a process that is time limited by the 
reproductive cycle of the model organism and may miss edits not produced in the 
germline cells [161]. X. laevis can take up to 12 months to reach sexual maturity, ruling 
this method out as too impractical for the given timeframe of this project. 
As expected, there is also more at play than just mosaicism. Tlr4 is not the only receptor 
of the innate immune system and certain pathways of innate immune activation may 
introduce redundancy to the Tlr4 -LPS pathway. A clear candidate is ‘Toll-like receptor 
2’, or TLR2, a receptor protein from the same family as Tlr4 that specialises in the 
recognition of lipoproteins and peptidoglycan, making it especially capable of detecting 
gram-positive bacteria [162]. Like Tlr4, TLR2 activation is linked to the NF-kB pathway, 
which is known to be linked to regeneration [1, 62]. TLR2 activation is also linked to 
signalling by the cytokine Interleukin-11 [163], which induces and maintains 
progenitors of different cell lineages during X. laevis tail regeneration [164]. Another 
example is the receptor ‘Nucleotide-binding oligomerization domain-containing protein 
2’, or NOD2, which recognizes bacterial molecules containing a specific structure called 
muramyl dipeptide (MDP) and is also linked to shared pathways such as NF-kB [165]. 
Even with perfect removal of the Tlr4 receptor with CRISPR editing, the innate immune 
response, although weakened, may still take place due to these alternate pathways of 
activation. Purified LPS, being the specific antigen of Tlr4 receptors, was used to control 
for these alternate pathways of innate immune activation, although contamination of 
the LPS extracts was a possibility that had to also be controlled for. RNase, DNase, and 
Proteinase treatment of each LPS extract was carried out to further purify the LPS, 
which was assessed with a Coomassie Blue protein stain run concurrently with the 
silver staining (Figure 14). All samples returned a negative result for protein 
contamination, except for a very faint band observed in the Chryseobacterium LPS 
extract. Coomassie Blue staining is very sensitive, thus the incredibly faint band 
observed in this sample is not indicative of severe protein contamination. When 




and therefore alternate immune activation pathways can be confidently ruled out as a 
major contributor to these results.  
So, why did this successful tlr4 knockdown lack correlation between editing level and 
regenerative success at the individual level? Perhaps mosaic editing left enough 
unedited copies of the tlr4 gene to cause the required immune response for 
regeneration, in a manner similar to haploid sufficiency [166]. Or perhaps the immune 
response was somehow triggered through alternate pathways that do not rely on Tlr4. 
The true answer is likely more complicated than simply a combination of these factors, 
however, I believe they offer the strongest explanation for the observed results. If time 
had permitted, further analysis of mRNA and protein levels of Tlr4 using techniques 
such as qPCR or western immunoblotting may have assisted in understanding the 
relationship between the achieved edits and observed regeneration. Another interesting 
avenue for future research would be to simultaneously knockout/knockdown known 
alternate innate immune activation pathways and observe the impact this has on 
regeneration under the conditions analysed in this thesis. One potential method for this 
is the introduction of multiple CRISPR/Cas sgRNAs targeting different regions of the 
genome simultaneously, a tactic that was trialled extensively throughout this project, 
but ultimately could not be achieved successfully. 
4.1.5 Combination sgRNA theory 
Introducing multiple sgRNAs simultaneously allows multiple genomic target sites to be 
edited in one organism and is an effective method of avoiding mosaic editing with 
CRISPR/Cas9, as eluded to earlier. Over the course of this research project, a substantial 
effort went into a range of experiments that were aimed at achieving just that. Two 
sgRNAs targeting tlr4 were co-injected into X. laevis embryos to induce the excision of 
the entire region between the two sgRNA target sites, knocking out the gene without 
having to rely so heavily on the inherent frameshift frequency of either sgRNA alone 
[167]. An added benefit of this method of tlr4 deletion is the ease of detection of 
successful edits, as the difference in PCR product size between successfully and 
unsuccessfully edited samples is large enough to be detected by PCR agarose gel 
electrophoresis alone. sgRNA rank 15, being the most distal sgRNA from the 
transcription start site and the first sgRNA discovered to be effective, formed the base of 




once in an attempt to cause a large deletion. The combinations of sgRNA trialled and the 
distance between the associated cut sites are listed in Table 24. The number of 
nucleotides between the cut sites of each sgRNA combination was not divisible by three, 
thus perfect excision of these regions would also result in a translational frameshift. 
Table 24: Combinations of sgRNAs trialled throughout this project. Note: the 
combination of sgRNA rank 15 with rank 2 includes the excision of intron 2 which is not 
included in this calculation.  
sgRNAs in 
Combination 
Distance Between Cut Sites 
Frameshift 
Nucleotides Amino Acids 
  Rank 15 + Rank 1 1271 423.6 +2 
  Rank 15 + Rank 2 1361 453.6 +2 
  Rank 15 + Rank 23 1274 424.6 +2 
  Rank 15 + Rank 29    184    61.3 +1 
  Rank 15 + Rank 50 1177 292.3 +1 
 
Obviously, for this theory to be successful two highly effective sgRNAs were required, 
and these experiments were run concurrently with the single sgRNA experiments, thus 
it was unknown at the time that only one sgRNA was effective. Upon discovery that only 
sgRNA rank 15 was working to a great enough extent, this method of tlr4 deletion had 
to be abandoned. However, these experiments were not entirely in vain as a great deal 
of experience was gained and some valuable lessons for the future learned, such as 
tailoring a PCR protocol towards the expected PCR product(s) and the careful selection 
of primers to manage said PCR product size.  
4.2 Natural variation between cohorts 
4.2.1 Batch variation in regeneration 
One fact that may have become apparent throughout this thesis is the variation in 
regenerative success between cohorts, even in the untreated control groups. For an 
extreme example, Frog 1 from the commercial LPS-EK experiment (Figure 17, a.) had 
an untreated control group with perfect regeneration, scoring 3/3, while Frog F7 of the 
extracted LPS-CH experiment had an untreated control group with a regeneration score 




regenerative success of a batch of tadpoles was the quality of the eggs and sperm, which 
can be difficult to control for beyond visual inspection of the resulting embryos for 
developmental abnormalities. Embryos which exhibited any developmental 
abnormalities were excluded to control for any effect these may have had on tail 
regeneration. For that reason, the number of tadpoles which made it to the regeneration 
scoring phase of each experiment was often far lower than the number of tadpoles 
included from the beginning of the experiment (normally 50 embryos injected per 
sgRNA).  
It has already been shown by our lab that successful tail regeneration correlates with 
skin microbiome composition [1], so to control for this, each cohort was cultured 
separately from one another to avoid cross contamination of skin microbiomes. Cas9 
has been proven not to cause deleterious effects when microinjected into X. laevis [126], 
however, Cas9 is still a foreign protein with regards to the X. laevis embryo, thus any 
effect on regeneration was controlled for by the inclusion of a Cas9-only injected control 
group for each sgRNA experiment. Even with these control measures in place, the 
natural variation in regeneration success was apparent. A potential explanation for this 
is the sensitivity of each cohort to the refractory period between stages 45 and 47, 
where some cohorts may have experienced the loss of regenerative ability to a greater 
extent, or at a marginally different time than other cohorts. One theory of batch 
variation being interrogated currently by our lab group is the effect of specific bacterial 
composition within the skin microbiome and its effect on tail regeneration. For example, 
in Figure 20, b. and c., identical concentrations of LPS from Chryseobacterium and 
Delftia were applied to the tadpoles of Frog C10 and C8, respectively. In the C10 cohort, 
Delftia LPS was better able to rescue regeneration of gentamicin treated tadpoles, while 
in the C8 cohort it was the Chryseobacterium LPS that was more effective. These results 
suggest the specific form of LPS, and therefore the specific gram-negative bacteria, 
present in the skin microbiome may impact tail regeneration differently by cohort. In 
addition to the questions raised regarding the impact of skin microbiome composition, 
an important consideration for future research is the impact of total bacterial load on 
batch variation. Natural fluctuation in bacterial levels present in the skin microbiome of 




4.2.2 Batch variation in survival rate 
Besides the observed variation in regenerative capability, there was also significant 
variation in the survival rate between each cohort of tadpoles. The quality of the eggs 
and sperm was again the most significant factor impacting survival rate, with poor 
quality embryos being primarily responsible for the low number of tadpoles observed 
in some experimental groups. However, following the poor survival of the β cohort 
tadpoles, the valid question arose as to what effect microinjection of an sgRNA had on 
survival. As this was my first attempt at microinjecting X. laevis embryos, the 
exceedingly high death rate was likely down to experimental error. The needle used to 
microinject these embryos was not fine enough and had a jagged edge, leading to a 
larger than optimal wound in the embryo membrane. Significant improvements in 
technique thankfully limited this issue to only the β cohort, although this did not 
entirely rule out an effect on survivability by sgRNA injection. Indeed, if tlr4 proved to 
be critical for the survival of X. laevis, then targeting it for deletion by CRISPR/Cas would 
be expected to lower survival rate. It has been shown, however, that detection of 
CRISPR edited cells which carry frameshift mutations in a gene indicate that the gene is 
non-essential for cell survival [168]. From a logical standpoint this makes sense, as no 
cells with a frameshift mutation would have survived if the gene were critical for 
survival. As many frameshift inducing edits were detected in the tail DNA of surviving 
tadpoles, tlr4 must not be critical for survival of the tadpole. 
A final consideration on the survival rate of injected embryos is the toxicity of the 
sgRNA, and the potential off-target effects it may have. As is the case when introducing 
any foreign construct into an embryo, RNA is known to be toxic to cells, with toxicity 
depending on the composition and concentration of the RNA [169]. According to the 
CHOPCHOP readout for sgRNA rank 15, the most likely off-target within the X. laevis 
v9.2 genome contains three mismatches relative to the sgRNA rank 15 sequence, 
making it exceedingly unlikely that any off-target editing took place.  
4.3 The impact of LPS on regeneration 
Switching focus from the Tlr4 receptor to its ligand lipopolysaccharide yielded some 
very interesting results. Four forms of LPS from gram-negative bacteria were analysed 
during this research project to characterise their impact on regenerative success. Part of 




staining, selected due to the extremely sensitive nature of this assay for the detection of 
bacterial LPS [170]. The purpose of this technique was primarily to confirm the 
presence of LPS in the extracted samples, not to elucidate the specific structure of each 
form of LPS, thus comments made here are only inferences on LPS structure, not 
confirmation. Two of the analysed forms of LPS were that of E. coli, including one 
commercially sourced LPS extract, and one in-lab extracted form. These two forms of 
LPS from the same species of bacteria produced strikingly different banding patterns 
when silver stained and run through acrylamide gel electrophoresis (Figure 13). 
Although it was known that the commercial E. coli and the E. coli utilised for LPS 
extraction were different strains, the disparity between these banding patterns was 
surprising.  
The commercial E. coli LPS was from the strain E. coli-O55:B5, named for its O-antigen 
(type 55) and its flagella (type B5). The details surrounding the complex structure and 
naming convention of LPS O-antigens exceeds the scope of this thesis; suffice to say that 
E. coli-O55:B5 harbours smooth-type LPS [171], which agrees with the ladderlike 
banding pattern observed in Figures 13 and 15. The strain from which LPS was 
extracted in-lab was Top10 Competent E coli, a sub strain of K-12 E. coli also known as 
DH10B. A thorough search through the literature returned no information regarding the 
LPS structure of Top10 Competent E. coli specifically. It should be noted, however, that 
this strain of E. coli has been engineered to easily take up DNA plasmids via a process 
called transformation. It has been shown that smooth type LPS, with its long O-antigens, 
may hinder the transformation process [172]. Thus, smooth-type LPS bacterial strains 
engineered for the purpose of transformation experiments are often mutated to reduce 
the length of their O-antigens [173]. This supports the resulting banding pattern 
produced by the LPS extracted from the Top10 Competent E. coli which indicated there 
were few, if any, repeating units present in the O-antigen (Figure 13). In agreement 
with the research preluding this project, where the addition of heat killed E. coli rescued 
regeneration in tadpoles where it had otherwise failed [1], the addition of purified LPS 
from E. coli (commercial or extracted) was sufficient to rescue the regeneration of 
gentamicin treated tadpoles (Figure 19). This result was the first concrete supporting 
evidence for the role that the LPS molecule specifically plays in the regeneration of X. 




Both Chryseobacterium and Delftia were genera of gram-negative bacteria that were 
overrepresented in the skin microbiome of tadpoles for which tail regeneration was 
successful relative to those where it failed [3]. To interrogate this correlation, LPS was 
extracted from a species of Chryseobacterium isolated directly from skin swabs of adult 
female X. laevis, and from Delftia, ordered from Landcare. Both species of bacteria were 
cultured and had their LPS extracted in-lab. Species level identification of these bacteria 
could not be achieved during the timeframe of this thesis, although it seems likely that 
the strain of Chryseobacterium is novel.  
The silver stain for Chryseobacterium LPS (LPS-CH) was the hardest to interpret (Figure 
13 and 15). Two bands roughly 55kDa and 65kDa in size were the most distinct feature 
of the banding pattern produced by LPS-CH (especially visible in Figure 15), although 
these bands were produced by every form of LPS analysed in this project. There is little 
consensus in the literature as to the apparent molecular size of LPS, but according to 
Sigma Aldrich, when treated with SDS and heat, as the LPS extracts of this project were, 
whole LPS molecules and/or aggregates of molecules have an apparent molecular 
weight of ~50-100 kDa and their constituent parts ~10-20kDa. This interpretation 
matches nicely with the banding visible across all samples of LPS, including LPS-CH, as 
being aggregates of LPS molecules. The only other detail of note for LPS-CH was a very 
faint band visible at ~35kDa in both the silver stain and Coomassie Blue protein stain 
(Figure 14). LPS has been reported to associate closely with membrane proteins when 
silver stained [174] and a very low level of protein contamination would explain the 
signal in the Coomassie Blue gel. As stated before, silver staining and Coomassie Blue 
staining are extremely sensitive, thus the very faint nature of this band indicates that 
protein contamination levels were very low. When applied exogenously to gentamicin 
treated tadpoles, the extracted LPS-CH was at least as effective as the commercial LPS-
EK positive control at rescuing regeneration. In three out of five cohorts tested, LPS-CH 
treatment rescued regeneration of the gentamicin treated tadpoles to the same level as 
untreated control tadpoles. These results indicate that Chryseobacterium on the skin of 
X. laevis tadpoles positively contributes to successful tail regeneration.  
The LPS extracted form Delftia (LPS-DF) tells a very similar story, although a clearer 
understanding of its structure could be gleaned from the silver stain in Figures 13 and 




bacteria contains smooth-type LPS. The application of LPS-DF to gentamicin treated 
tadpoles again demonstrated the ability of these LPS extracts to rescue regeneration, as 
all three cohorts in which LPS-DF was trialled displayed an increase in regenerative 
success as a result of the intervention. This included two out of the three cohorts that 
received LPS-DF treatment displaying regeneration to the same extent as the untreated 
controls.  
The final form of LPS to be extracted and trialled was that of Rhodobacter sphaeroides 
(LPS-RS). The LPS of these gram-negative bacteria was of particular interest due to the 
fact that it has the precise opposite effect on Tlr4 to the other forms of LPS under 
scrutiny here, acting as an antagonist to Tlr4 activation. Unfortunately, due to the 
prohibitively high price of purchasing commercial LPS-RS, a comparison between the 
commercial LPS-RS and the in-lab LPS-RS extract via silver staining could not be carried 
out (Figure 15). The extracted LPS-RS produced a banding pattern surprisingly similar 
to that of Top10 Competent E. coli (extracted LPS-EK) and extracted Delftia LPS, with a 
strong band at roughly 35kDa present in all three of these LPS samples. The R. 
sphaeroides LPS, however, lacked the ladderlike pattern produced by the Delftia LPS, a 
result conducive to rough-type LPS. The Lipid A structure of LPS from R. sphaeroides 
differs from that of the other forms of LPS tested here, containing only five fatty acids 
compared to the six fatty acids in the Lipid A component of the other LPS forms [139]. 
This difference in Lipid A structure did not manifest in an obvious alteration in banding 
pattern relative to the other LPS samples.  
The true area of interest regarding the LPS of R. sphaeroides, however, was in its impact 
on tail regeneration. Whereas the agonistic forms of LPS were applied to gentamicin 
treated tadpoles which had no interfering skin microbiome, LPS-RS was applied to 
untreated tadpoles, and thus had to compete for Tlr4 activation against the LPS present 
in the natural skin microbiome. The commercial LPS-RS treatment produced the 
expected decrease in mean regeneration in one of the two cohorts in which it was 
trialled (Figure 17, a.). The extracted LPS-RS, on the other hand, was able to produce 
this expected decrease in regenerative success in both cohorts in which it was trialled 
(Figure 22), potentially owing to the fact that extracting the LPS directly from bacterial 
stock allowed higher concentrations to be trialled without exhausting the supply of LPS-




MD2 [140] and has been shown to inhibit the function of other LPS-MD2 complexes at 
Tlr4 [99, 175]. This supports the notion that a higher concentration of LPS-RS stands a 
better chance of saturating the Tlr4 receptors of the tadpole, blocking their activation to 
a greater extent. LPS-RS provides an extreme example of the impact that variation in 
LPS structure can impose on Tlr4 activation, further highlighting the importance of skin 
microbiome composition in regeneration.  
The results gathered throughout these LPS experiments make for a compelling 
argument in support of the hypothesis posed by this project: that the specific 
interaction between LPS and Tlr4 is linked to regenerative success in X. laevis tadpoles. 
Treatment with LPS extracted from gram-negative bacteria that activate the innate 
immune receptor Tlr4 was shown to increase the relative success of tail regeneration. In 
the special case of a form of LPS which antagonises the Tlr4 receptor, regenerative 
success was reduced. Additionally, it seems the specific composition of the skin 
microbiome may have an impact on regeneration, as the different forms of LPS 
produced by different gram-negative bacteria have the potential to affect regeneration 
differently. An avenue that could not be explored during my time on this project is the 
effect that changes in temperature may have on X. laevis tail regeneration. As mentioned 
in the introduction, the skin microbiome is dynamic, with some species of gram-
negative bacteria altering the structure of their LPS in response to environmental cues 
including temperature [94]. Temperature was controlled at 18°C using an incubator 
throughout this project, however, it would be intriguing to assess whether alterations in 
temperature would significantly affect regenerative success, and whether this could be 
linked to alterations in LPS structure. This would further highlight the important role 












A successful CRISPR/Cas knockdown of the gene encoding Toll-like receptor 4 was 
achieved in X. laevis embryos, which was carried through to stage 46 tadpoles. Tadpoles 
carrying this tlr4 knockdown correlated with reduced tail regeneration on average, 
however, a correlation between CRISPR/Cas editing and regenerative outcome was not 
observed at the level of individual tadpoles. Culturing X. laevis tadpoles in the broad-
spectrum antibiotic gentamicin was confirmed to markedly reduce regenerative success 
following tail amputation. The exogenous application of lipopolysaccharide, the ligand 
that activates Tlr4, was sufficient to rescue tail regeneration in tadpoles cultured in 
gentamicin. Additionally, when lipopolysaccharide from R. sphaeroides, known to be 
antagonistic to Tlr4 activation, was applied to untreated tadpoles, a reduction in 
regenerative success was observed. These results support the hypothesis that 
amputation of the tail exposes host innate immune receptors, including Tlr4, to bacteria 
from the skin microbiome of the tadpole. Lipopolysaccharide present in the outer 
membrane of gram-negative bacteria within the skin microbiome activates Tlr4, 
inducing an immune response that is required for successful regeneration of the 
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Appendix 1A: sgRNA sequences and predicted editing statistics, as described by 
CHOPCHOP. Stock concentrations were determined by Nanodrop spectrophotometry 











Rank 1 CCGGTAACCCAATACGCCATTGG 51.4 77.3 656.0 
Rank 2 TAGAGTACCTTGATCTCACCAGG 59.3 78.0 563.6 
Rank 15 GATGAGATTGTCGGAGATCCAGG 50.3 48.4 528.4 
Rank 23 TGTGGATCCCAATGGCGTATTGG 48.7 80.0 596.4 
Rank 29 CTGTGGATTATACGGGTTGGAGG 46.2 87.1 423.3 
Rank 50 GAGGGAAGTTACATTTCTCAAGG 53.3 91.3 499.5 
 
Appendix 1B: DNA oligo sequences produced by the EnGen sgRNA Oligo Template 
Designer and ordered from Integrated DNA Technologies. 
sgRNA DNA Oligo Sequence 
Rank 1 TTCTAATACGACTCACTATAGCCGGTAACCCAATACGCCATGTTTTAGAGCTAGA 
Rank 2 TTCTAATACGACTCACTATAGTAGAGTACCTTGATCTCACCGTTTTAGAGCTAGA 
Rank 15 TTCTAATACGACTCACTATAGATGAGATTGTCGGAGATCCGTTTTAGAGCTAGA 
Rank 23 TTCTAATACGACTCACTATAGTGTGGATCCCAATGGCGTATGTTTTAGAGCTAGA 
Rank 29 TTCTAATACGACTCACTATAGCTGTGGATTATACGGGTTGGGTTTTAGAGCTAGA 









Appendix 2A: Forward primer sequences for PCR amplification of the target site of 
each sgRNA, as described by CHOPCHOP. 
sgRNA Forward Primer Sequence 
Melting 
Temperature (°C) 
Product Size (bp) 
Rank 1 TGAGGATCTAGCATTTTCAGGC 60.7 229 
Rank 2  AGCTTCAACCCCCTTAGACATA 59.8 288 
Rank 15 ATTCCTGAAGGGACTTTTTCGT 60.3 221 
Rank 23 AAATTGTGTTTCTCTGCAGGTG 60.7 266 
Rank 29 GCCTTCATTAATATGCCACATC 58.5 231 
Rank 50 ATTGGGATCCACAGTCATTTTT 60.4 287 
 
Appendix 2B: Reverse primer sequences for PCR amplification of the target site of each 
sgRNA, as described by CHOPCHOP. 
sgRNA Reverse Primer Sequence 
Melting 
Temperature (°C) 
Product Size (bp) 
Rank 1 TGTCGTGAGATGCAGAGATTTT 59.9 229 
Rank 2  CATGGGCCTTATTTGAGTGATG 59.5 288 
Rank 15 GAACAGTCAAAAGGGTTTCCTG 60.0 221 
Rank 23 TGTCGTGAGATGCAGAGATTTT 59.9 266 
Rank 29 TTCTGGAAAACCACACTCAAAA 59.6 231 











Appendix 3: The 1kb Plus DNA Ladder used for determination of DNA length. By 
comparing the brightness of a sample band to that of the nearest sized ladder band, an 









Appendix 4: Example of electrophoresis of LPS extract on a 2% agarose gel for 
assessment of DNase and RNase treatment. ‘Before’ refers to LPS extract saved from the 
step prior to DNase and RNase treatment, ‘After’ refers to LPS extract from after this 
step. Some DNA/RNA contamination is still present in the LPS extract after this cleaning 





Appendix 5A: Electrophoresis of PCR product from the M7 embryo cohort following T7 
Endonuclease assay on a 1% Agarose gel. The contents of each lane are listed along the 



















Appendix 5B: Example of the results produced by TIDE analysis of M7 embryo #5 
injected with sgRNA rank 2, compared to a Cas9-only injected negative control. (a) 
Insertions and deletions detected by TIDE, graphed by InDel size (X-axis) against 
frequency of detection in the sample (Y-axis). (b) Frequency of aberrant sequences 
detected (Y-axis) plotted against base pair location relative to the sgRNA rank 2 cut site 
(X-axis), i.e. how much the sample sequence differs to the control sequence due to 
insertions and deletions caused by sgRNA rank 15. In this example, TIDE analysis 







Appendix 6: Regeneration scores for the tadpoles of the β cohort. Due to a high death 
rate, few tadpoles from this cohort survived with no developmental abnormalities to 




sgRNA rank 15 
(1:5) 
sgRNA rank 15 
(1:3) 
Full 7 3 0 
Partial Good 3 10 3 
Partial Bad 0 2 1 
None 0 0 1 




















Appendix 7A: The first attempt at electrophoresis of LPS extracts on a 10% acrylamide 
gel with silver staining. A Novex Sharp protein marker was loaded in the first well and 
the size of the protein bands are labelled on the left in kDa. The contents of each well are 
labelled along the top and a gap was left between each sample, denoted by “[ ]”. This gel 
is slightly overdeveloped, ripped in the top left corner, and the bottom of the gel is 













Appendix 7B: The first electrophoresis of LPS extracts on a 10% acrylamide gel with 
Coomassie Blue protein staining. A Novex Sharp protein marker was loaded in the first 
well and the size of the protein bands are labelled on the left in kDa. The contents of 
each well are labelled along the top and a gap was left between each sample, denoted by 
“[ ]”. This gel returned a negative signal for protein contamination in all LPS extracts. 
The bottom of this gel is also missing from the photograph. 
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